Weekly healthcare intelligenceRegulation · Enforcement · Government payersNews & Sweeps →
Complete approved report · Medicare & Medicaid

Medicare & Medicaid, week of Oct 4, 2026

Published October 11, 2026 Coverage Oct 4, 2026 to Oct 10, 2026 Listed sources reviewed through Oct 10, 2026 Last modified Oct 16, 2026 Version 3

Read this edition’s coverage note ↓

Read corrections to this edition (version 3). The original publication date is unchanged.

Executive triage

October 13 APM cutoff and youth-care transition, followed by October 15 clinic edit

  • Unpaid qualifying APM participants must submit billing information by October 13 to avoid incentive forfeiture.
  • Medi-Cal youth-care preparation must preserve exceptions, required notices and HCAI continuity before October 13.
  • FQHC, RHC, IHS-MOA and Tribal FQHC institutional claims need diagnoses from October 15.
  • ALW eligibility and claim evidence should be reconciled with possible reprocessing.
  • BHSA claiming starts January 2027; DMEPOS bid dates and HCBS reporting have separate phases.
  • Plan STPHH transitions, January ASCMI consent workflows and QNC funding changes on their separate phased dates.

What changed since last week

Compare with the previous published edition, Oct 4, 2026. Labels describe each development's lifecycle; absence from this list does not mean an obligation closed.

Findings, highest priority first

Each card leads with priority, lifecycle, applicability, and deadline, then the detail.

P1 CARRYOVER Directly applicable Final implementation Oct 5, 2026

CMS revises the October NCD coding update and moves stem-cell changes to April 2027

What changed

The September 24 transmittal rescinds R13910 and removes the stem-cell business requirements for a separate April 2027 change request. October 1 service-date effectiveness and October 5 implementation otherwise remain, subject to the individual retrospective dates. Remaining cardiac PET instructions change tracer parameters and edits, while bone-density codes 0554T through 0558T are added for diagnostic indications from January 1, 2024, with corresponding frequency and cost-sharing edits. The bone-density additions expressly exclude monitoring indications.

Other retained requirements add implantable-defibrillator procedure codes from April 2026, revise aprepitant-related coding, add C88.40 for Breyanzi from its December 4, 2025 FDA approval date, and add 0648U for the Oncomine test from July 2026. These dates are specific to their requirements, rather than one blanket October coverage expansion. MACs must adjust affected claims brought to their attention without searching previously processed claims. CMS characterizes the release as coding maintenance, with NCD policy changes left to the established determination process.

Why it matters
Verify the implemented release scope and review affected claims without treating the removed stem-cell requirements as active October edits. Code maintenance alone does not expand underlying coverage criteria.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, IT, Compliance
First seen
Sep 27, 2026
Last materially changed
Sep 27, 2026
Why it is still here
Current transmittal scope and business requirements read October 11; retained for post-implementation reconciliation. The linked ZIP spreadsheets and actual contractor implementation were not inspected.

What to do nextCoding and IT should reconcile deployed CR 14464 tables with the replacement scope; Revenue Cycle should identify affected retrospective claims for MAC attention and retain outcomes. Verify actual coverage criteria before rebilling.

  1. Reconcile deployed edits with the replacement transmittal and remove deferred stem-cell changes from the October scope. Coding · due Oct 12, 2026
  2. Test applicable claim cases against actual NCD criteria and identify retrospective adjustments for MAC attention. Revenue Cycle · due Oct 16, 2026
  3. Retain vendor and contractor implementation evidence; do not treat the future April CR as released. IT · due Oct 16, 2026
P1 CARRYOVER Directly applicable Final implementation Oct 1, 2026

Noridian posts MolDX billing-article revisions for October 1

What changed

For October 1, A57891 adds M04.3; A59868 adds Q87.A; and A60217 adds K74.0A. A59872 replaces I42.0 and I42.8 with more specific cardiomyopathy codes, while A57037 replaces I42.0 with I42.00, I42.01, and I42.09. These annual code changes have different scope from the other revision entries: A59872 separately dates its I42.1 and I42.2 additions to September 25, 2025, and the sequencing-code inclusion language in A57891 and A57901 is effective May 17, 2020. A55595 describes its September 24 change as a revised hyperlink.

The MASLD/MASH article A60217 retains operational limits beyond its new diagnosis code: one test per patient per twelve months, one unit of service, the appropriate DEX identifier, and at least one diagnosis from each of the liver-dysfunction and cardiometabolic-risk groups. The amyloidosis and aortic-disease articles point to the DEX registry for tests evaluated against coverage criteria. The sequencing articles expressly caution that inclusion of 81455 and 81456 does not imply coverage and does not adequately define a particular service. Reviewing implemented edits therefore requires the relevant article and testing conditions, rather than treating this bundle as one new blanket testing benefit.

Why it matters
California laboratories and ordering providers need to confirm that applicable October 1 coding, documentation and claim edits are operating correctly. The effective date has passed; code inclusion alone does not establish coverage.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Revenue Cycle
Affected functions
Clinical Operations, Revenue Cycle, Coding, Compliance
First seen
Sep 27, 2026
Last materially changed
Sep 27, 2026
Why it is still here
Retained to validate applicable October coding and test-specific billing controls after current operative article review; the prior September revisions remain historical.

What to do nextInventory the revised articles that apply to current testing, reconcile the implemented October 1 changes with local edits and order workflows, and sample current claims for diagnosis, DEX identification and test-specific coverage requirements. Correct any implementation gaps promptly.

  1. Identify revised MolDX articles tied to tests currently ordered or billed and confirm the applicable LCD criteria. Clinical Operations · due Oct 12, 2026
  2. Reconcile implemented October 1 coding, documentation and claim edits; correct any gaps. Coding · due Oct 13, 2026
  3. Sample current claims and document any remaining coding or coverage-control failures. Revenue Cycle · due Oct 14, 2026
P1 CARRYOVER Operationally relevant Effective effective Oct 1, 2026

Hospice election addendum is mandatory for every new election starting October 1

What changed

The October 1 newsletter says the FY 2027 hospice payment rule makes the election statement addendum mandatory for all elections on or after October 1. Hospices must furnish it in writing, on paper or electronically, to the beneficiary or representative within five calendar days of the election's effective date. It must contain the information required by 42 CFR 418.24(c). An update is due within three calendar days of a plan-of-care change, so the initial delivery workflow does not complete every later addendum obligation.

CMS describes the payment condition as satisfied when a valid signed addendum is in the beneficiary's hospice medical record. From October 1 through December 31, MACs will not deny claims solely because the addendum is missing or incomplete and will focus on education. The newsletter expressly says furnishing remains required for every electing beneficiary during that window. This temporary enforcement discretion therefore changes the stated claims response to specified documentation defects, while leaving the October 1 furnishing requirement and the need to correct omissions in place.

Why it matters
Election documentation affects payment and patient understanding of excluded services. The temporary non-denial policy is a transition allowance, not an optional addendum.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Revenue Cycle
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The operative newsletter section was reread. Ongoing election workflows remain material after implementation; October through December enforcement discretion does not make the addendum optional.

What to do nextValidate October elections, delivery dates, signatures, excluded-service explanations and the three-day update workflow. Correct omissions promptly.

  1. Audit October elections, five-day delivery, signatures and three-day updates; correct omissions. Internal target. Clinical Operations · due Oct 12, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P1 CARRYOVER Operationally relevant Final effective Oct 13, 2026

Medi-Cal youth gender-affirming services: October 13 reimbursement and continuity requirements

What changed

The September 30 letter limits reimbursement from October 13 for specified gender-affirming surgery, puberty blockers, and hormone therapy for Medi-Cal members under eighteen and CHIP members under nineteen. Hormones already being taken as of October 13 retain a transition through April 12, 2027; for affected MCP members, this applies only under the medical benefit. Surgery, blockers, and newly started hormones receive no such transition. Services for other medical indications and treatment of complications remain covered when medically necessary.

The letter preserves necessary ancillary services, earlier service dates, and unaffected ages. It directs coordination with HCAI state-only funding and says providers should not cancel or redirect care while reimbursement details develop. Plans must distribute approved handbook errata and issue individualized adverse-action notices when required, with ten-day advance notice where applicable, appeal rights, and continuation information. Policies, attestation, and copies are due within ninety calendar days of release, rather than requiring subsequent DHCS approval.

Why it matters
The letter preserves medically necessary ancillary care, treatment for other indications and complications, pre-October 13 services, and unaffected ages. HCAI state-only funding supports continuity; providers should not cancel or redirect care while reimbursement details develop.
Response type
Escalate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California, Federal
Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Case Management, Revenue Cycle, Legal
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The complete current six-page letter was visually read by the machine. The imminent service-date transition remains material; later court status and Attachment A were not independently verified.

What to do nextValidate exceptions and HCAI coordination immediately. Distribute the approved handbook errata and assess individualized adverse-action notices, including ten-day advance notice where applicable, appeal rights and continuation of benefits. Confirm the December 29 policy-submission target.

  1. Confirm affected services, exceptions, notices and continuity; internal target. Managed Care · due Oct 12, 2026
  2. Apply service-date controls and coordinate HCAI funding. Revenue Cycle · due Oct 13, 2026
  3. Submit policies and required confirmation within 90 days of release. Managed Care · due Dec 29, 2026
P1 NEW Directly applicable Announced

DHCS warns assisted living waiver facilities of denials and reprocessing

What changed

DHCS says routine Assisted Living Waiver oversight has identified claiming issues requiring Care Coordination Agencies and facilities to take corrective action. Claims may be nonpayable for failure to satisfy program requirements, and previously paid claims are under review for possible reprocessing when payment was erroneous. The notice therefore addresses both prevention of new denials and reconciliation of earlier payments, rather than guaranteeing that an existing payment is final or asserting that every facility billed improperly.

Facilities must verify ALW eligibility before delivering services and submitting claims through DHCS/CCA processes, comply with program and contract standards, use correct codes and modifiers, and maintain accurate claiming documentation. DHCS says additional information will be tailored to facilities with nonpayable claims. Questions go to the ALW claims support address with the facility's name and NPI. That individualized process makes actual eligibility evidence and correspondence material; the public notice does not supply a general deadline or authorize assuming the same correction applies to every resident.

Why it matters
Facilities and care coordination agencies must verify ALW eligibility, program compliance, correct codes and documentation. The notice announces oversight and facility-specific follow-up, without inventing a universal correction deadline.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Case Management, Compliance, Finance

What to do nextValidate eligibility and service evidence before billing; reconcile prior payments and preserve facility-specific correspondence. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Match active ALW members to approved eligibility confirmation and care-coordination records. Case Management · due Oct 18, 2026
  2. Sample billed services, modifiers and supporting documentation; correct identified noncompliance. Revenue Cycle · due Oct 18, 2026
  3. Reconcile any reprocessed claims and escalate facility-specific DHCS correspondence. Finance · due Oct 25, 2026
P1 NEW Directly applicable Final implementation Oct 15, 2026

Medi-Cal clinic institutional claims require diagnosis codes from October 15

What changed

The October 9 notice requires at least one clinically appropriate ICD-10-CM diagnosis on UB-04 or 837I claims submitted on or after October 15 by FQHCs, RHCs, IHS-MOA 638 providers, and Tribal FQHCs. It points to existing outpatient UB-04 completion instructions and says updated manual sections will follow in a future Medi-Cal Update. The scope is the listed providers and institutional claim formats; the announcement does not state that every professional claim changes or that older service dates exempt a claim submitted after the trigger.

Why it matters
The trigger is claim submission, rather than a new date-of-service limit. DHCS says corresponding provider manual updates will follow.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, IT, Clinical Operations

What to do nextAdd the diagnosis edit to affected institutional claim workflows and test before October 15. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Identify affected provider types and UB-04/837I claim queues. Revenue Cycle · due Oct 12, 2026
  2. Test clinically appropriate diagnosis population and reject missing-code claims internally. IT · due Oct 14, 2026
  3. Monitor submissions and remittances from October 15 and resolve coding exceptions. Coding · due Oct 15, 2026
P1 NEW Directly applicable Effective compliance Oct 13, 2026

Unpaid qualifying APM participants face October 13 billing-information cutoff

What changed

CMS’s October 5 correction repairs the missing download hyperlink in its August 13 advisory for qualifying Alternative Payment Model participants. The advisory concerns the 2026 incentive, equal to 1.88 percent of the applicable 2025 professional-service payment base for clinicians who qualified in 2024. CMS could not identify a taxpayer identification number for some recipients. Those clinicians, and others expecting an unpaid incentive, are directed to provide updated Medicare billing information and required documentation by October 13, 2026.

The advisory says timely submissions will be held and processed after the response period closes, and warns that late claims to the payment will be forfeited. The October correction changes the hyperlink, not that cutoff. Finance and enrollment teams should reconcile the unpaid-participant notice against actual NPI/TIN records and preserve submission evidence. An inconsistent later reference to a 2025 incentive does not change the advisory’s stated 2024 qualification, 2025 base and 2026 payment sequence.

Why it matters
The advisory concerns 2024 QP performance, a 2025 payment base and the 2026 incentive payment, with forfeiture after October 13. Listed unpaid clinicians and others expecting an unpaid incentive should follow the official instructions. One later paragraph says 2025 incentive; that apparent source inconsistency is not silently treated as a different payment period.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Provider Enrollment, Revenue Cycle, Quality

What to do nextFinance and enrollment owners should check the official unpaid-QP notice, reconcile NPI/TIN records and submit the required billing documentation by October 13. Confirm receipt and retain the submission.

  1. Check the official unpaid-QP notice against expected incentives and current NPI/TIN records. Recommended internal target. Finance · due Oct 12, 2026
  2. Submit required billing documentation by the agency October 13 cutoff. Provider Enrollment · due Oct 13, 2026
  3. Retain submission evidence for subsequent payment reconciliation. Revenue Cycle · due Oct 13, 2026
P2 CARRYOVER Directly applicable Announced

CMS reports $1.6 billion in Medicare laboratory program integrity actions across revocations, suspensions, recoupments and referrals

What changed

The August release reports $732 million in savings from 157 enrollment revocations, over $500 million halted through 185 suspensions, over $276 million recouped from 442 overpayments, and $127 million prevented through 85 referrals. CMS describes analytics targeting nonexistent services, unsupported necessity or ordering relationships, and upcoding. Suspended funds, estimated savings, and recovered payments are distinct outcomes; the aggregate is not one adjudicated recovery or new October filing requirement.

The October 1 MLN reminder addresses a related billing control: panels and individual tests should be reviewed for duplication, but medically necessary repeats remain payable when applicable requirements are met. CMS identifies modifier 91 for repeat clinical diagnostic laboratory tests and points to its manual and coding guidance. It separately describes the 2027 PFS request for information on duplicate testing and result sharing as exploration for future rules. That consultation does not turn every repeat test into noncoverage or establish a new universal submission date.

Why it matters
The categories measure different outcomes and should not be described as one adjudicated recovery. CMS identifies nonexistent services, unsupported necessity and ordering relationships among its laboratory scrutiny signals.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Compliance, Revenue Cycle, Coding, Clinical Operations, Provider Enrollment, Finance, Legal
First seen
Aug 30, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The current full release and October 1 duplicate-testing guidance were reread. Risk monitoring remains material; no new general duty was identified in these sources.

What to do nextRevenue Cycle and Compliance should review relevant laboratory volume, ordering support and enrollment controls, and escalate actual payment or revocation notices. This is an internal readiness recommendation.

  1. Sample high-risk laboratory claims and reconcile ordering and necessity support. Internal target. Compliance · due Oct 18, 2026
  2. Confirm billing-identifier enrollment and escalation ownership. Internal target. Provider Enrollment · due Oct 18, 2026
P2 CARRYOVER Directly applicable Final effective Oct 12, 2026

Noridian finalizes two MolDX coverage policies for California effective October 12 and retires the thrombophilia policy October 11

What changed

Noridian's August notices finalize hereditary-thrombophilia LCD L40242 and non-NGS targeted-cancer-panel LCD L40222 for the listed Jurisdiction E contracts, with companion coding articles A60272 and A60239. The prior thrombophilia LCD L36155 retires October 11 because L40242 supersedes it. CMS specifies services performed on or after October 12 for the replacement's commencement. Retirement and next-day implementation are the material carryover events, rather than publication of a new October policy.

L40242 requires a qualifying clinical setting, management-relevant hereditary testing, appropriate validated genetic content, repeat-testing limits, and a satisfactory MolDX technical assessment. L40222 requires treatment-informing tumor testing and either infeasible NGS or the specified rapid, accurate alternative, together with validation and assessment requirements. Its negative non-NGS result may be followed by NGS covering additional necessary content; that exception does not waive the other criteria. Neither policy makes every named test covered, and references to companion articles do not replace their actual coding instructions.

Why it matters
Laboratories must use the operative indications and coding articles for hereditary thrombophilia and non-NGS targeted cancer panels. Retirement alone does not establish that every test becomes noncovered; each service must satisfy the applicable policy.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California, Hawaii, Nevada
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations, Compliance, Utilization Management, HIM/CDI
First seen
Aug 30, 2026
Last materially changed
Aug 30, 2026
Why it is still here
Current Noridian notices and CMS effective-date/coverage sections were rechecked. The immediate retirement and next-day implementation remain material; organization-specific completion is not known.

What to do nextCoding and laboratory owners should complete the indication, technical-assessment and coding crosswalk today, implement the date-of-service rules October 12, and assess beneficiary notices where applicable. Review actual claims after implementation.

  1. Complete the laboratory indication, technical-assessment and coding crosswalk; confirm outstanding work immediately. Internal target. Coding · due Oct 11, 2026
  2. Apply service-date controls for the finalized policies and assess beneficiary notices where applicable. Revenue Cycle · due Oct 12, 2026
  3. Sample implementation claims and resolve policy-mapping errors. Internal target. Compliance · due Nov 13, 2026
P2 CARRYOVER Potentially applicable Proposed comment Oct 26, 2026

CMS proposes a new annual Acute Hospital Care at Home reporting requirement, comments close October 26

What changed

CMS’s August 27 Paperwork Reduction Act notice proposes a new Acute Hospital Care at Home Quantity, Intensity, and Mix of Services data collection tool, CMS-10971. The agency is seeking a new OMB control number and public comments by October 26, 2026. Its annual burden estimate is 365 respondents, 13,000 responses and 13,000 hours. Comments may address whether the collection is necessary and useful, whether the burden estimate is accurate, and whether clearer requirements or automated collection could reduce that burden. This is a proposed information collection, rather than evidence that OMB has approved or activated a new reporting obligation.

The notice links the tool to the Consolidated Appropriations Act of 2026 requirement for CMS to evaluate care delivered through the hospital-at-home initiative. Participating hospitals receive individual waivers at the CMS Certification Number level. CMS says the proposed information would describe services for patients admitted from an emergency department or transferred from an inpatient unit and support a report to Congress. Clinician visits, food services and pharmacy services are examples within the proposed quantity, intensity and mix measures, not an exhaustive three-field specification. The notice points to supporting statements and forms for further detail; it does not itself establish a final data dictionary, first reporting period or submission deadline.

Why it matters
A participating hospital can use the comment period to test how the proposed quantity, intensity and mix measures relate to its documentation and data systems. The notice provides a proposed reporting burden, not evidence that most programs lack the needed data or that a final reporting obligation is already in effect.
Response type
Comment
Confidence
High
Who this affects
Health systems
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Quality, HIM/CDI, Finance, Case Management
First seen
Aug 30, 2026
Last materially changed
Aug 30, 2026
Why it is still here
The October 26 comment period remains open for this edition. Participating hospitals still have a specific decision about commenting on the proposed collection and assessing the burden against their existing documentation; approval or activation by OMB has not been established.

What to do nextConfirm whether the organization participates in Acute Hospital Care at Home. Ask the program and data owners to compare current documentation with the proposed collection, including clinician visits, food and pharmacy services, and decide by October 26 whether to comment on the burden estimate or collection design. Treat these as preparation and comment decisions, not a new active reporting deadline.

P2 CHANGED Directly applicable Final effective Oct 1, 2026

Medi-Cal directory administrators must confirm successful submissions

What changed

The August notice starts a 45-day completion period on October 1 and requires providers to update or validate directory information within 45 days in each following quarter. Administrators must answer whether every service location accepts new fee-for-service patients, managed care patients, or both, then save the completed directory. Failure to complete required quarterly updates removes Transaction Center access for all users in the organization. Processors who lose access are directed to their administrator to update the directory and restore it, rather than treating the issue as an individual user's password problem.

The October 6 notice reiterates administrator review and confirmation of successful submissions. It schedules an October 13 virtual question-and-answer session from 10 to 11 a.m. for system and provider impacts. Patient names, birth dates, record numbers, and other PHI or PII must not be discussed there. Unlike the October 1 PP401PNC training notice, which requires a Medi-Cal Learning Portal profile and course selection, the office hour does not require MLP pre-enrollment. Neither educational route substitutes for completing and saving the recurring directory survey.

Why it matters
Incomplete quarterly directory updates can interrupt Transaction Center access for every user in an organization. Reliable ownership, a backup, location-specific patient-access information and confirmation of successful saving help protect eligibility, claims and other transaction workflows. These operational recommendations support the recurring requirement.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Revenue Cycle, Compliance, IT, Patient Access

What to do nextIdentify every Medi-Cal Provider Portal administrator the organization has and confirm each one knows the obligation starts October 1, 2026. Name a primary and a backup owner per organization identifier, and put the validation on a recurring quarterly calendar rather than treating it as a single task. Before the first submission, confirm with patient access and the service line owners whether each service location is in fact accepting new fee for service patients, managed care patients, or neither, so the directory answer matches practice. Confirm the escalation path if Transaction Center access is lost, since restoring it depends on the administrator completing the directory. The October 1 notice links the PP401PNC training course for the existing directory workflow.

  1. Inventory every Medi-Cal Provider Portal organization identifier the organization holds and identify the current administrator for each. Provider Enrollment · due Sep 18, 2026
  2. Name a primary and a backup administrator per organization identifier and confirm both can reach the Provider Portal Directory survey. Provider Enrollment · due Sep 25, 2026
  3. Confirm with patient access and the service line owners, per service location, whether the location is accepting new fee for service patients, managed care patients, or neither. Patient Access · due Oct 9, 2026
  4. Complete and save the first directory validation inside the window that opens October 1, 2026, and record the submission date. This target date sits well inside the 45 day window rather than at its end. Provider Enrollment · due Oct 31, 2026
  5. Put the validation on a recurring quarterly calendar with the named owners, and confirm the escalation path if Provider Portal Transaction Center access is lost. Revenue Cycle · due Nov 13, 2026
P2 CARRYOVER Operationally relevant Pending litigation effective Oct 13, 2026

California challenges Medicaid and CHIP funding restrictions scheduled for October 13

What changed

The September 2 Attorney General announcement reports a coalition challenge to the final HHS rule and states an October 13 effective date unless a court intervenes. It describes the affected federal reimbursement as gender-affirming care for persons under 18 in Medicaid and under 19 in CHIP. The coalition asks the Massachusetts federal district court to block the rule and disputes HHS's authority and justification. Those positions remain attributed litigation arguments, rather than judicial findings.

DHCS's October 5 stakeholder item distinguishes federal funding restrictions from California's continued reimbursement for medically necessary care. It says California will use state-only funds through HCAI and identifies September 30 All Plan Letter 26-018 for Medi-Cal managed care plans. The AG statement likewise says the rule permits state-only funding and does not prohibit providers from furnishing care. These sources support contingent funding and continuity planning; they do not verify any subsequent court order or supply all implementing claims instructions.

Why it matters
Payment planning requires distinguishing the final rule, California funding policy and any later court order. This draft has not verified a subsequent injunction.
Response type
Assess
Confidence
Moderate
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Legal
Affected functions
Legal, Managed Care, Revenue Cycle, Clinical Operations
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Funding and continuity preparations remain material two days before the stated federal date. The announcement and current DHCS funding summary were read, but later docket status remains unresolved.

What to do nextLegal and Managed Care should verify the docket and DHCS instructions, map affected funding streams and continuity-of-care needs, and prepare contingent billing instructions. Do not change patient care solely on the lawsuit announcement.

  1. Verify court orders and current DHCS payment direction before issuing operating instructions. Legal
  2. Identify affected claims and continuity-of-care workflows by funding source. Managed Care
  3. Prepare billing changes contingent on operative legal requirements. Revenue Cycle
P2 CARRYOVER Operationally relevant Announced

OIG identifies $587.7 million in Part D payments involving obsolete prescription labeling

What changed

The audit, issued August 31 and posted September 2, found payments continuing more than a year after associated brand-name drugs switched to over-the-counter use. OIG attributes the five-drug payment problem to outdated FDA data in CMS's formulary reference file and the absence of a CMS timeframe for sponsors to reject these claims. The $587.7 million is the audit's finding of ineligible payments during 2021–2023, rather than an announced recovery completed this October.

OIG distinguishes a December 2025 FDA policy requiring generic manufacturers to update labels as early as possible and within six months from its recommendation that CMS issue sponsor payment-rejection guidance. CMS concurred, but the retained recommendation tracker lists the guidance recommendation open and unimplemented. The manufacturer's labeling period should therefore not be substituted for an already implemented universal sponsor rejection deadline. Monitoring reference data and Rx-to-OTC changes is a control response to the audit, with later implementing CMS direction still material.

Why it matters
Obsolete labeling and reference data can leave drug eligibility controls behind regulatory changes. The audit does not itself establish a new universal rejection deadline.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Revenue Cycle
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Pharmacy and Managed Care owners should assess Rx-to-OTC monitoring, reference-file updates and claims review with counsel, and monitor implementing CMS guidance.

What to do nextPharmacy and Managed Care owners should assess Rx-to-OTC monitoring, reference-file updates and claims review with counsel, and monitor implementing CMS guidance.

P2 CARRYOVER Operationally relevant Announced

OIG flags organ acquisition reimbursement and documentation risks

What changed

OIG's audit, issued September 1 and posted September 3, examines organs reported as Medicare usable during 2017–2022. In a sample of 180 organs, Medicare reimbursed acquisition costs for 43 not used in Medicare-covered transplants and 12 not transplanted at all. OIG extrapolates about $380 million across the six-year period. It identifies a conflict between statutory limits and CMS guidance that assumes organs furnished to another transplant center or procurement organization will be used for a Medicare transplant.

Two centers also lacked support for five organs, producing a separate $154,210 unallowable-reimbursement finding. OIG recommends MAC recovery of that amount and revision of CMS guidance to count only organs transplanted into Medicare enrollees. CMS concurred with the recovery recommendation but did not specifically concur or nonconcur with the guidance recommendation; the retained tracker shows both open. The nationwide estimate, the two-center documentation finding, and a later entity-specific collection must therefore remain separate when assessing records and reimbursement exposure.

Why it matters
The estimate is not a blanket recoupment notice. Transplant centers face a documented conflict between CMS guidance and statutory requirements identified by OIG.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Clinical Operations, Compliance, Legal
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Finance and transplant operations should trace organ counts to disposition and supporting records, consult counsel on the guidance conflict, and monitor MAC instructions before treating the estimate as an organization-specific liability.

What to do nextFinance and transplant operations should trace organ counts to disposition and supporting records, consult counsel on the guidance conflict, and monitor MAC instructions before treating the estimate as an organization-specific liability.

P2 CHANGED Directly applicable Effective effective Sep 1, 2026

Medi-Cal hospice attestation reminder emphasizes correct NPI selection

What changed

Organizations with multiple NPIs must select the correct provider in the upper-right portal selector before opening Medi-Cal Hospice Attestation in the Transaction Center. The reminder says that selection makes the attestation available and ties it to the appropriate provider record. If it remains unavailable after that check, the Telephone Service Center handles access assistance; the Hospice Clerk handles program questions.

The FAQ describes the September 1 portal transition without a grace period, warns that submissions outside five calendar days can cause denials, and limits mandatory portal attestation to fee-for-service members. Managed-care procedures remain separate. DHCS 8052 documents election and consent and stays in the member's medical record for requested review or audit.

Why it matters
Late submission can cause claim denial. The FAQ limits this portal to fee-for-service providers; managed care providers follow their plan procedures. The signed DHCS 8052 informed-consent form remains in the medical record and is not submitted through the portal.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Revenue Cycle, Provider Enrollment, IT, Compliance

What to do nextConfirm provider-NPI access immediately. Assign admission staff to submit and retain confirmation within five calendar days of each election; check elections since September 1 for missed submissions and contact DHCS about exceptions or access problems.

  1. Confirm access for each fee-for-service hospice NPI and identify any admissions awaiting attestation. Provider Enrollment · due Sep 8, 2026
  2. Reconcile September elections to portal confirmations, retain informed consent, and escalate missed five-calendar-day submissions to DHCS. Clinical Operations · due Sep 8, 2026
  3. Check submission timeliness and associated claim outcomes during the first month; internal review date is not a DHCS extension. Compliance · due Sep 30, 2026
P2 CARRYOVER Potentially applicable Final implementation Jul 1, 2027

AB 280 establishes provider directory reliance protections

What changed

AB 280 directs the departments to designate a central utility and establish directory standards and annual consistency checks. Its additions and amendments do not apply to Medi-Cal managed care contracts. Covered plans must review reports and attest how they will remedy each inconsistency. The exclusive-provider exception applies to specified nonprofit arrangements with at least 3.5 million enrollees and a single medical group; providers contracted with multiple plans remain subject to the utility requirement. General acute-care hospitals are exempt from specified verification, removal, and reinstatement paragraphs, rather than every directory duty. Accurate reinstatement requests must be approved within ten business days.

The reliance remedy requires the department to find that a member reasonably relied on materially inaccurate, incomplete, or misleading directory information, and to conclude that the received services were covered benefits. The plan or insurer must then hold the member to applicable in-network cost sharing and provide the specified reimbursement; the provider may not collect an additional balance. This protection is not unconditional payment for any service whenever a directory contains an error. July 1, 2027 is the statutory compliance date, while actual utility designation and implementing standards still require confirmation.

Why it matters
California plans and insurers may need to migrate provider-directory collection and validation to the state-selected central utility and uniform standards.
Response type
Assess
Confidence
Moderate. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Patient Access, Compliance, IT
First seen
Sep 6, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Directory and contracting teams should map the central utility, notice, reliance and reinstatement requirements to affected products and validate member workflows before the operative date. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
Long lead justification
The July 1, 2027 provider-directory deadline exceeds 180 days, but central-utility integration, directory validation and member reliance workflows require coordinated Managed Care, IT and contracting preparation. Monitor agency designation and standards; this proposal does not treat those steps as completed. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextDirectory and contracting teams should map the central utility, notice, reliance and reinstatement requirements to affected products and validate member workflows before the operative date.

  1. Confirm covered plan products, hospital exclusions and directory utility responsibilities. Managed Care · due Nov 1, 2026
  2. Map directory accuracy, notice, reliance and reinstatement workflows to the final provisions. Patient Access · due Mar 1, 2027
  3. Test integration and member-facing processes before the July 1 operative date. IT · due Jul 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 350 expands fluoride treatment coverage and guidance

What changed

For qualifying contracts or policies issued, amended, or renewed from January 1, 2027 that already cover pediatric fluoride varnish, AB 350 requires medically necessary application without cost sharing whether billed as medical or dental care. Specialized coverage and Medicare supplements are excluded, and Medi-Cal managed-care contracts are excluded from the commercial plan provision. If the new requirement creates state benefit-defray obligations without an appropriation, the specified commercial requirement ceases to apply. The bill does not erase existing federal preventive-service obligations.

For Medi-Cal beneficiaries under 21, DHCS must issue billing guidance and necessary policy updates by July 1, 2027 consistent with EPSDT and utilization controls. The provision allows place-of-service flexibility, but qualified professionals must act within scope, complete appropriate training, and work under an enrolled licensed provider who bills for their services. That provider must retain training records for review or audit. Community health workers are included, with other nonlicensed practitioners dependent on DHCS designation. Implementation remains conditioned on available federal participation and necessary approvals, rather than independent billing authority for every trained staff member.

Why it matters
California plans, insurers, Medi-Cal operations, and pediatric providers may need benefit and claims configuration for medically necessary fluoride treatment without cost sharing.
Response type
Assess
Confidence
Moderate. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, IT, Compliance, Clinical Operations
First seen
Sep 6, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Separate commercial benefit configuration from Medi-Cal implementation; confirm approved scope, provider eligibility and DHCS billing guidance before changing claims rules. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextSeparate commercial benefit configuration from Medi-Cal implementation; confirm approved scope, provider eligibility and DHCS billing guidance before changing claims rules.

  1. Confirm affected benefits, contracts, statutory conditions and applicable dates. Managed Care · due Oct 18, 2026
  2. Separate commercial benefit configuration from Medi-Cal implementation; confirm approved scope, provider eligibility and DHCS billing guidance before changing claims rules. Managed Care · due Jan 1, 2027
  3. Test revised workflows and member or provider communications before implementation. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1682 adds qualifying scalp cooling coverage

What changed

Large-group contracts or policies issued, amended, or renewed from January 1, 2027 must cover prescribed FDA-cleared scalp cooling around alopecia-inducing chemotherapy. Cost sharing may apply, but cannot be less favorable than oncology supportive care. Non-FDA-cleared cold caps are excluded, as are specialized commercial coverage and Medi-Cal managed-care contracts under the commercial provision.

Medi-Cal has a separate prescribed scalp-cooling benefit subject to medical necessity and utilization controls. Its definition likewise excludes non-FDA-cleared products. Implementation depends on necessary federal approvals and available, unjeopardized federal participation; DHCS may issue administrative instructions. These conditions preclude assuming immediate universal reimbursement or applying the large-group mandate to every individual or small-group policy.

Why it matters
Large-group plans and insurers may need benefit, medical-necessity, authorization, and claims configuration for prescribed scalp cooling used with chemotherapy.
Response type
Assess
Confidence
Moderate. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, IT, Clinical Operations, Compliance
First seen
Sep 6, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextConfirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement.

  1. Confirm affected benefits, contracts, statutory conditions and applicable dates. Managed Care · due Oct 18, 2026
  2. Confirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement. Managed Care · due Jan 1, 2027
  3. Test revised workflows and member or provider communications before implementation. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1876 strengthens health plan nondiscrimination protections

What changed

The law protects enrollment and benefits on race, color, national origin, age, disability, and sex, including intersex traits, pregnancy, sexual orientation, and gender identity. It prohibits discriminatory benefit designs, claims restrictions, cost sharing, and categorical gender-transition exclusions. Disability protections include appropriate integrated settings and serious risks of institutionalization or segregation.

Legitimate nondiscriminatory clinical appropriateness, coverage requirements, and reasonable medical management remain permitted; bias or pretext does not. Plans and insurers must provide nondiscrimination and grievance information. These protections do not guarantee every service regardless of medical necessity. The ordinary January 2027 date is grounded separately in the official constitutional effective-date rule.

Why it matters
California plans and insurers may need to test enrollment, benefit, claim, and cost-sharing rules for discrimination on the protected bases stated in the bill.
Response type
Assess
Confidence
Moderate. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Compliance
Affected functions
Compliance, Legal, Managed Care, IT, Patient Access
First seen
Sep 6, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Test enrollment, benefit, claim and member service workflows against the protected bases; revise escalation and denial review controls. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextTest enrollment, benefit, claim and member service workflows against the protected bases; revise escalation and denial review controls.

  1. Confirm affected benefits, contracts, statutory conditions and applicable dates. Compliance · due Oct 18, 2026
  2. Test enrollment, benefit, claim and member service workflows against the protected bases; revise escalation and denial review controls. Managed Care · due Nov 15, 2026
  3. Test revised workflows and member or provider communications before implementation. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final implementation May 26, 2028

AB 2499 sets a future electronic exchange standard for claim support

What changed

From May 26, 2028, the amended plan and insurer provisions require a standard electronic method for medical records and supporting documents necessary to process claims. File-size limits must accommodate typical documentation needed for adjudication, and receipt must be confirmed electronically. A carrier may not deny, pend, or delay a claim solely because its systems cannot accept documentation meeting the stated requirements. Electronic submission may use the designated portal or the specified interoperable exchange route.

The rule preserves denials, pending status, and delays otherwise authorized by law. It does not apply while circumstances outside the carrier's reasonable control impair electronic acceptance, including outages, disasters, or cybersecurity incidents. A later state or federal standard addressing file size, number, or other capacity requirements governs if adopted. These limits make intake capability and disruption handling material while leaving the statute's separate claims-payment framework distinct; May 2028 is not a new start date for every existing payment clock.

Why it matters
Plans and insurers may need claims-intake capacity for electronic medical records and supporting documents, including controls that prevent delays caused only by system limitations.
Response type
Assess
Confidence
Moderate. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Managed Care, Compliance, Finance
First seen
Sep 6, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map current claim attachment workflows and vendor dependencies to the final exchange requirements; verify implementation milestones as standards and guidance develop. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
Long lead justification
The May 26, 2028 electronic-documentation requirement exceeds 180 days, but claim-attachment formats, payer interfaces, vendor capacity and receipt confirmation require an early technical inventory and procurement planning. Keep existing payment clocks separate and confirm later capacity standards and exceptions before implementation. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextMap current claim attachment workflows and vendor dependencies to the final exchange requirements; verify implementation milestones as standards and guidance develop.

  1. Inventory supporting claim information formats and affected payer interfaces. Revenue Cycle · due Nov 15, 2026
  2. Confirm the final exchange standard and vendor dependencies as implementation specifications become available. IT · due Jun 1, 2027
  3. Test affected claims support workflows before the expressly stated operative date. Compliance · due May 26, 2028
P2 CARRYOVER Directly applicable Announced implementation Sep 30, 2026

CMS announces broad state participation in the GENEROUS Medicaid drug payment model and a September 30 signing date

What changed

The September 18 release reports applications from all 50 states, DC, and Puerto Rico, with 40 states and Puerto Rico then signed. Those counts describe different stages of participation. CMS presents the model as most-favored-nation pricing for certain covered outpatient drugs and forecasts $64.3 billion in savings over ten years. The estimate is a projection, rather than a realized recovery, and the release does not establish that every applicant or drug had entered an operative agreement.

Under the described arrangement, participating manufacturers provide prices through supplemental rebates invoiced by states under their agreements. CMS monitors price accuracy and shares rebates through reductions in the federal Medicaid share. The release says the model launched in January 2026 for five years and gave remaining states until September 30 to sign. By this October 11 edition, that date is historical. Actual California execution, manufacturer participation, and applicable terms remain necessary before converting the announcement into formulary, invoice, or operational instructions.

Why it matters
State participation can change supplemental-rebate administration, invoice reconciliation, pharmacy finance forecasts, and state-federal accounting. California organizations should monitor the state terms and downstream formulary or access effects.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Finance, Compliance, IT
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Confirm California participation status and assigned state owner, inventory supplemental-rebate and federal-share workflows, and identify any data, invoice, formulary, or manufacturer-contract changes needed before operational instructions issue.

What to do nextConfirm California participation status and assigned state owner, inventory supplemental-rebate and federal-share workflows, and identify any data, invoice, formulary, or manufacturer-contract changes needed before operational instructions issue.

  1. Confirm California participation status and the state implementation contact. Managed Care · due Sep 23, 2026
  2. Map supplemental-rebate invoicing, manufacturer data, and federal-share reconciliation dependencies. Finance · due Sep 30, 2026
  3. Monitor DHCS instructions for formulary, claims, or reporting changes. Clinical Operations · due Oct 7, 2026
P2 CARRYOVER Operationally relevant Announced

CMS expands ACCESS to heart failure, COPD, substance use disorder, nicotine dependence, and extended musculoskeletal care in spring 2027

What changed

CMS's September 15 announcement adds heart failure, COPD, substance-use disorders, and tobacco-cessation support to ACCESS beginning spring 2027, with specified musculoskeletal conditions eligible for support beyond the initial twelve-month care period. It describes technology-supported care between visits, potentially including coaching, remote monitoring, virtual care, and connected devices. Payment is tied to measured health improvement rather than solely individual services. The announcement identifies the direction of expansion but supplies no detailed new-track application deadline or complete measurement specification.

ACCESS itself supports people with Original Medicare; Medicare Advantage enrollees are excluded, although their plans may offer similar programs. CMS describes participation as voluntary without adverse changes to beneficiaries' benefits, coverage, or provider choice. The release reports 160 participating organizations at launch and a directory for evaluating covered conditions and providers. Separate pledges by major payers to align outcome-based payment structures do not enroll their members in ACCESS or prove a provider has accepted model obligations. Referral and integration decisions therefore depend on actual participation and track terms.

Why it matters
Provider organizations may need referral, consent, device, data-exchange, clinical oversight, and outcomes-reporting workflows before the new tracks open. Payers are also aligning outcome-based payment structures to the model.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Managed Care, IT, Compliance, Finance
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Identify eligible service lines and referral owners, assess data and device integration, and compare current chronic-care contracts with ACCESS outcome measures before deciding whether to participate or refer.

What to do nextIdentify eligible service lines and referral owners, assess data and device integration, and compare current chronic-care contracts with ACCESS outcome measures before deciding whether to participate or refer.

  1. Assign service-line owners for the five added ACCESS tracks. Clinical Operations · due Oct 4, 2026
  2. Assess referral, consent, remote-monitoring, device, and outcomes-data readiness. IT · due Oct 18, 2026
  3. Prepare a participation or referral recommendation when CMS posts track specifications. Managed Care · due Nov 1, 2026
P2 CARRYOVER Directly applicable Final implementation Oct 5, 2026

CMS replaces the October EDI transmittal to update its 276/277 attachment

What changed

R13977 expressly rescinds September 18 R13967 and updates the 276/277 flat-file attachment, leaving the other instructions unchanged. It retains October 1 effectiveness and October 5 implementation for the quarterly CCEM front-end edits used by Medicare contractors and shared systems. The earlier two-error correction belongs to the superseded September 18 version; the current cover describes an attachment update. That distinction supports identifying the actual installed release rather than treating every September file as equivalent.

The instruction requires the attached spreadsheets to replace prior versions and explains that the change-log tab contains current-version modifications. Contractors need not repeat completed work but must incorporate the updates. Business requirements address TA1 and 999 acknowledgments, test data, and translator/CCEM flat-file layouts, including 276/277. These are contractor technical directions; the provider action is to verify clearinghouse or vendor implementation and investigate relevant acknowledgment or claim-status exceptions. A published implementation date alone does not establish that an organization installed the correct attachment.

Why it matters
Clearinghouses, billing systems, and revenue-cycle teams that implemented the superseded spreadsheet may apply incorrect front-end edits or misread claim-status responses beginning October 1.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Compliance, Finance
First seen
Sep 20, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The September 28 replacement remains material after October 1 effectiveness and October 5 contractor implementation. Remaining work is to validate the actual R13977 attachment and relevant acknowledgments; organization-specific deployment has not been established.

What to do nextConfirm that the clearinghouse or vendor deployed R13977OTN and its current 276/277 attachment. Compare affected front-end and claim-status scenarios with the replacement change log, review actual acknowledgments and exceptions, and document any remaining release or configuration gap.

  1. Replace the superseded 276/277 edits spreadsheet in implementation materials. Revenue Cycle · due Sep 23, 2026
  2. Regression-test corrected front-end edit and claim-status scenarios with vendors. IT · due Sep 27, 2026
  3. Confirm production deployment and exception monitoring before the effective date. Revenue Cycle · due Oct 1, 2026
P2 CARRYOVER Directly applicable Final

California limits added billing barriers for Medi-Cal providers after other coverage pays

What changed

For a noncontracted provider billing a Medi-Cal managed-care plan for allowable costs left unpaid by other coverage, DHCS must prevent requirements significantly exceeding those for billing the same costs through fee-for-service. A separate provision bars requiring a fee-for-service participating provider to become an in-network contractor to bill allowable covered costs when the other coverage is not Medicare. The Medicare exclusion belongs to that second provision; it should not be generalized to erase the separate comparative administrative-burden rule.

Plans may still require agreements for specified prior-authorization or other-payer-uncovered services and for qualifying continuity-of-care arrangements. Without an agreement, a provider may bear amounts above fee-for-service rates or applicable service limits, but cannot bill the beneficiary for excess unpaid amounts. DHCS may clarify billing, update guidance, and take specified administrative actions, with legislative updates from 2027 through 2030. Implementation depends on necessary federal approvals and available, unjeopardized federal participation. The statute therefore does not itself prove that all approval conditions have been completed or that every noncontracted claim is payable.

Why it matters
Plans need claims and provider-relations rules that accept eligible noncontracted-provider bills without adding prohibited network or administrative barriers.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, Compliance, IT
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; ongoing implementation or monitoring remains: Compare coordination-of-benefits edits, noncontracted-provider billing rules, and letter-of-agreement practices with the enacted limits, then prepare changes that activate after required federal approval and funding.

What to do nextCompare coordination-of-benefits edits, noncontracted-provider billing rules, and letter-of-agreement practices with the enacted limits, then prepare changes that activate after required federal approval and funding.

  1. Map noncontracted-provider billing requirements after other coverage pays. Managed Care · due Oct 16, 2026
  2. Identify edits or network requirements that exceed fee-for-service rules. Revenue Cycle · due Oct 30, 2026
  3. Prepare implementation pending federal approval and funding. Compliance · due Nov 13, 2026
P2 CARRYOVER Directly applicable Final implementation Jan 1, 2027

CMS finalizes 2027 Ambulatory Specialty Model participation and reporting steps

What changed

The September 17 newsletter says the mandatory ASM final participant list for the 2027 performance year is available. It directs specialists frequently treating Original Medicare patients for outpatient low back pain or heart failure to check whether they were selected. Selected participants must meet model requirements, including required measures and attestations. Specialty or service-line identity alone does not establish an individual clinician's selection, and the newsletter does not reproduce the participant roster.

CMS says future Medicare Part B payments for participants will be adjusted according to performance on reported measures and activities. That creates a connection between model reporting, source-data quality, and future payment review, without establishing the complete measures or attestation calendar in this short notice. Its September 30 office hour is already past as of October 11; the model page, participant materials, and FAQs remain the referenced routes for detailed instructions. No organization-specific reporting completion or selection is established here.

Why it matters
Selected participants need accountable owners for attestations, reporting, measure data, and finance controls before the 2027 performance period.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Quality, Finance, IT, Compliance
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; remaining operational task: Confirm selection status, assign an executive owner, calendar each CMS reporting and attestation step, and test source data before the 2027 model year.

What to do nextConfirm selection status, assign an executive owner, calendar each CMS reporting and attestation step, and test source data before the 2027 model year.

  1. Confirm whether the organization appears on the final participant list. Clinical Operations · due Oct 2, 2026
  2. Inventory reporting and attestation requirements. Quality · due Oct 16, 2026
  3. Test measure and payment source data. IT · due Nov 13, 2026
P2 CHANGED Directly applicable Final implementation Nov 1, 2026

Noridian coverage updates include November tendon-injection conformity revisions

What changed

The published November 1 revisions pair L34218 revision 7 with A57079 revision 6 and describe administrative conformity to the chronic-pain peripheral-nerve policy L40265. The tendon/ligament/ganglion LCD addresses injections used within an overall treatment plan. Symptoms should resolve or be reevaluated after one to three injections; more than three injections at the same local site within six months require clinical justification for prior failure and an expectation of further benefit. The policy also questions repeated injections or more than two sites per session and excludes the described dry-needling procedures.

The companion billing guidance requires records supporting the diagnosis and decision to inject, additional justification for repeat treatment, and compliance with applicable correct-coding edits. Insufficient supporting documentation can lead to a medical-necessity denial. November 1 remains the future revision date as of October 11; these published documents should not be represented as already replacing the October version. Clinical justification and coding review remain separate from simply loading a revised article number. The public extract does not establish that every license-gated code table or individual claim satisfies the policy.

Why it matters
These are administrative conformity revisions under the listed JE Part B contractors, including California. The notices do not create blanket coverage for injections. The four earlier nerve-procedure and molecular-diagnostic updates remain a separate carryover research checkpoint pending current verification.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Utilization Management, Clinical Operations, Compliance

What to do nextCompare tendon-injection criteria and coding edits with the operative LCD and article before November 1; separately recheck the four prior notices. Playbook dates are recommended internal targets.

  1. Compare L34218 and A57079 conformity changes with operative L40265 criteria. Coding · due Oct 18, 2026
  2. Recheck prior notices and test affected service-line documentation and edits. Utilization Management · due Oct 25, 2026
  3. Verify claim configuration before the November effective date. Revenue Cycle · due Oct 30, 2026
P2 CARRYOVER Directly applicable Final implementation Jan 1, 2027

DHCS prepares a January 1 transition to fee-for-service for specified immigration-status coverage

What changed

The September stakeholder announcement identifies January 1, 2027 for moving members with unsatisfactory immigration status from managed care to fee-for-service Medi-Cal. The September 29 notice introduces a provider resource hub with news, training, FAQs, and further materials as available, alongside member/provider guidance on DHCS's transition page. DHCS states that this changes how care is delivered rather than whether members remain eligible, while conditioning continued full-scope coverage on timely renewal. The announcement should not be generalized to every immigration-status group or treated as eliminating individual eligibility and renewal requirements.

The provider notice says organizations billing only managed care and lacking Medi-Cal fee-for-service enrollment cannot continue caring for affected UIS members after December 31, 2026. It directs providers to update PAVE enrollment, confirm current enrollment, screening, and revalidation, review fee-for-service billing and Treatment Authorization Requests, and update whether they accept new fee-for-service members. These specific conditions make enrollment and service-capacity checks material to continuity planning; a managed-care contract alone does not establish readiness for fee-for-service claims or authorization workflows.

Why it matters
Plans and providers need member, authorization, continuity-of-care, billing, and referral workflows that account for the coverage-delivery transition.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Patient Access, Revenue Cycle, Case Management, Compliance, IT
First seen
Sep 20, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextConfirm current fee-for-service enrollment through PAVE, pending enrollment and revalidation, service authorizations and continuity capacity before January 1. Coordinate member-specific transitions with plans and DHCS.

  1. Identify affected members and services; confirm eligibility and continuity requirements individually. Managed Care · due Oct 18, 2026
  2. Confirm PAVE fee-for-service enrollment, screening and revalidation for every participating location and clinician. Provider Enrollment · due Nov 1, 2026
  3. Reconcile authorizations, referral pathways and fee-for-service capacity before the transition. Clinical Operations · due Dec 31, 2026
P2 CARRYOVER Directly applicable Final implementation Oct 5, 2026

CMS issues FY 2027 IPPS and LTCH implementation instructions

What changed

September 29 R13969 replaces R13930 to correct the Policy section and business requirement 14592.13 while leaving other information unchanged. The instruction retains October 1 effectiveness and October 5 implementation and generally addresses discharges October 1, 2026 through September 30, 2027 unless otherwise noted. It directs use of current final-rule or correcting-document tables and files, updated Pricer software, and version 44 grouper and Medicare Code Editor logic keyed to discharge date. Publication of those directions does not establish local installation.

The separate September 29 Federal Register document restores hospital CCN 250078, wrongly treated as converted to rural-emergency-hospital status, and corrects the rural classification of CCN 360068. CMS explains resulting recalculations of DRG weights, wage indexes, budget neutrality, outlier thresholds, standardized amounts, capital factors, and uncompensated-care factors, with related LTCH wage-index changes. These connected technical adjustments do not yield one uniform increase for all hospitals. Current hospital-specific files and actual October claim results remain the appropriate basis for reconciliation after implementation.

Why it matters
Hospitals need rates, coding, billing, quality, and finance systems aligned when the fiscal year begins October 1, 2026.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Finance, Coding, IT, Compliance
First seen
Sep 20, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for date-specific implementation and applicable claim testing after claim-specific current official instruction review.

What to do nextReconcile current FY 2027 IPPS/LTCH files with applicable hospital-specific wage and payment settings; investigate October claim variances and corrected fields with the MAC.

  1. Confirm final rate, code, and policy files are loaded. Revenue Cycle · due Oct 18, 2026
  2. Run and reconcile representative inpatient and LTCH test claims. IT · due Oct 18, 2026
  3. Validate October claim processing against the installed FY 2027 files and resolve payment variances. Finance · due Oct 18, 2026
P2 CARRYOVER Directly applicable Final implementation Jan 1, 2027

ACWDL 26-16: Pickle, DAC and DW asset-limit reinstatement

What changed

The September 17 letter restores January 1, 2027 limits of $130,000 for one person plus $65,000 per additional person, up to ten. New applications face asset verification; pre-January applications and earlier retroactive months remain protected. Existing members are tested at renewal or a qualifying change with assets verified ex parte, rather than all being retested January 1.

A qualifying 90-day cure restores timely eligibility. Property eligibility generally uses 12:01 a.m. on the first day, with distinct spenddown and medical-expense settlement rules. LTC transfer review excludes January 2024–December 2026 and grows to a full 30 months by July 1, 2029. These transition conditions require separate application and renewal workflows.

Why it matters
Eligibility screening, notices, documentation, and escalation paths need to apply the reinstated limits accurately for vulnerable members.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Patient Access
Affected functions
Patient Access, Compliance, IT, Case Management
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextReview ACWDL 26-16 with eligibility operations, update screening and notice procedures, train staff, and test representative cases before January 1, 2027.

  1. Map ACWDL 26-16 asset rules to affected eligibility groups. Patient Access · due Oct 9, 2026
  2. Update procedures, notices, and escalation instructions. Compliance · due Oct 30, 2026
  3. Test representative eligibility cases. IT · due Nov 20, 2026
P2 CARRYOVER Directly applicable Proposed comment Oct 21, 2026

CMS releases preliminary 2027 Clinical Laboratory Fee Schedule rates

What changed

The September 24 newsletter directs laboratories to preliminary calendar-year 2027 determinations for new tests and invites comments by October 21. Those determinations remain part of the annual rate-setting process. CMS identifies [email protected] as the comment address, making this a prospective opportunity to support a payment position rather than a statement that every proposed amount is already final.

The same notice separately links final 2026 Medicare Administrative Contractor gapfill recommendations for calendar-year 2027. Requests to reconsider those payment recommendations go to [email protected] by October 21. CMS says the gapfilled amount becomes final once the final, complete 2027 fee schedule is posted. A laboratory reviewing both files therefore needs to distinguish comments on a preliminary new-test determination from reconsideration of a MAC gapfill recommendation; the shared deadline does not make the two stages interchangeable.

Why it matters
Laboratories need to model rate effects and identify codes for which CMS should receive evidence before the comment window closes.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Clinical Operations, Revenue Cycle, Finance, Compliance
First seen
Sep 27, 2026
Last materially changed
Sep 27, 2026
Why it is still here
Current claim reviewed; remaining operational task: Model the preliminary rates against current volume, identify material changes, and submit supported comments or reconsideration requests by October 21.

What to do nextModel the preliminary rates against current volume, identify material changes, and submit supported comments or reconsideration requests by October 21.

  1. Model preliminary rates against current laboratory volume. Finance · due Oct 5, 2026
  2. Identify codes needing comment or reconsideration and assemble support. Clinical Operations · due Oct 12, 2026
  3. Submit any supported request before the CMS deadline. Revenue Cycle · due Oct 21, 2026
P2 CARRYOVER Directly applicable Proposed comment Oct 12, 2026

DHCS seeks comment on payment responsibility for psychiatric emergency services

What changed

The September 25 draft assigns MCP responsibility for emergency and post-stabilization care, including psychiatric emergencies and emergency-room professional and facility charges. It excludes specialty mental-health services provided after inpatient psychiatric admission. The index requests feedback at [email protected] by October 12; the document remains draft guidance.

The draft includes necessary psychiatric emergency care for voluntary patients and people detained under the Lanterman-Petris-Short Act. Fee-for-service pays when the person is not enrolled in an MCP, with the same inpatient specialty-service boundary. Proposed monitoring addresses medical necessity and documentation. These provisions clarify responsibility without making the comment deadline a new payment implementation date.

Why it matters
Managed care, behavioral health, emergency services, and claims teams may need consistent responsibility and handoff rules if DHCS finalizes the guidance.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Revenue Cycle, Compliance
First seen
Sep 27, 2026
Last materially changed
Sep 27, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextCompare the draft with current emergency and post-stabilization payment workflows, identify disputes or gaps, and submit supported feedback by October 12.

  1. Map current psychiatric emergency and post-stabilization payment workflows. Managed Care · due Oct 2, 2026
  2. Identify disputed responsibility rules and operational gaps. Clinical Operations · due Oct 7, 2026
  3. Submit supported feedback to DHCS. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Announced

OIG finds $72 million in MA and Part D payments tied to excluded or felony-convicted providers

What changed

The report was issued September 28 and posted October 1. OIG examined 1,017 NPIs associated with providers revoked from Medicare Parts A and B who were absent from the Preclusion List during 2022 and 2023. It identified $72 million in Part C and Part D payments to 249 of those NPIs during 2022 through 2024. The different analysis and payment periods matter: the reported payment total is not limited to the two years used to select the NPI population.

OIG attributes the vulnerabilities to timing problems and errors when providers were added to or removed from the list, and to omission of some organizations whose owners were excluded or had felony convictions. It also says current regulations do not subject pharmacies that only fill prescriptions, without prescribing Part D drugs, to preclusion. The brief offers information for possible future regulatory or guidance solutions and contains no specific CMS recommendations. It does not announce that revocation and preclusion are interchangeable or impose a new blanket recoupment instruction on plans.

Why it matters
Enrollment revocation, exclusion and preclusion are distinct. The summary also identifies a regulatory gap for dispensing-only pharmacies; it does not order blanket recovery of every payment.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Managed Care, Compliance, Revenue Cycle
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The current primary findings were read. The historical audit remains useful for delegated payment controls; no new mandate or current-week recovery was inferred.

What to do nextEnrollment and managed-care owners should reconcile applicable status sources, investigate discrepancies and obtain counsel review of payment consequences. These are internal control recommendations.

  1. Reconcile provider-status sources and investigate discrepancies. Internal target. Provider Enrollment · due Oct 18, 2026
  2. Review affected payments with counsel, without assuming a blanket repayment order. Internal target. Compliance · due Oct 18, 2026
P2 CARRYOVER Operationally relevant Final implementation Apr 1, 2027

GLOBE final model: manufacturer rebates and selected Part B drug coinsurance preparation

What changed

The October 2 final rule is effective November 30. The model begins January 1, 2027 with an initial reporting quarter for voluntary manufacturer-submitted international net-pricing data. Its five-year performance period begins April 1, 2027 and ends March 31, 2032; the payment period runs from April 1, 2027 through March 31, 2034 or completion of payment activities, if later, subject to the rule's early-termination provisions. Manufacturer rebate duties and beneficiary-facing payment operations therefore need to be distinguished from the initial voluntary data submission.

The model covers a defined Original Medicare Part B population rather than every Medicare beneficiary, and its coinsurance calculation concerns separately payable units of included model drugs furnished to model beneficiaries. CMS compares the payment amount with the lesser of the model benchmark and inflation-adjusted amount for the quarter. When the payment amount exceeds that comparison amount, coinsurance is calculated as twenty percent of the comparison amount; otherwise the specified ordinary coinsurance applies. Excluded drugs do not receive the model adjustment, and adjusted Medicare payment remains subject to other claim adjustments and the Part B deductible. These gates preclude a universal January change to all Part B patient estimates.

Why it matters
Infusion and specialty practices need to determine affected drugs and beneficiaries before changing billing or patient estimates. The final model is not a general replacement of every Part B payment rate.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Revenue Cycle, Clinical Operations, Managed Care
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for date-specific implementation and applicable claim testing after claim-specific current official instruction review.

What to do nextSeparate November rule effectiveness, January manufacturer data collection and April beneficiary/payment operations. Identify CMS-selected drugs and beneficiaries and test applicable coinsurance only after the quarter-specific instructions are available.

  1. Separate November rule effectiveness, January manufacturer data collection and April beneficiary/payment operations. Identify CMS-selected drugs and beneficiaries and test applicable coinsurance only after the quarter-specific instructions are available. Finance · due Apr 1, 2027
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CHANGED Operationally relevant Effective effective Oct 1, 2026

FY 2027 IPF payment correction changes per diem and ECT amounts

What changed

The October 1 correction changes the standard federal per diem amount to $912.13 and the ECT payment per treatment to $688.38. For providers failing quality-data reporting, the corresponding amounts are $894.29 and $674.93. Restoring an incorrectly excluded hospital's wage data changed the wage-index budget-neutrality factor from 0.9989 to 0.9986, which flowed into these rates. The October 8 R14000 replacement retains the FY 2027 discharge period, October 1 effectiveness, and October 5 implementation while clarifying the FTE resident-cap language.

The manual allows the cap to increase from July 1, 2026 for resident slots awarded under section 4122 of the CAA 2023, including qualifying IPPS-hospital awards allocated to an IPF subunit. It does not permit affiliation agreements to aggregate IPF teaching caps. Less-than-full-time residents and partial-year rotations count proportionately, and resident time counted for IPPS indirect medical education cannot also support the IPF teaching adjustment. Payment uses the lower of the cap and actual resident count. An award thus needs allocation and time support rather than automatically increasing every teaching payment by the nominal number of slots.

Why it matters
Small rate differences propagate across claims, budget models and vendor configuration. Using the uncorrected final-rule table can produce systematic discrepancies. The cap may increase for awarded resident slots from July 1, 2026, including qualifying IPPS-hospital slots allocated to an IPF subunit. Do not double-count resident time under IPPS IME or aggregate IPF caps through affiliation agreements.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations

What to do nextReconcile the corrected FY 2027 rates and awarded resident slots against the cost report, allocated training time and cap; retain support for the teaching adjustment. Recommended internal review targets do not change agency operative dates.

  1. Map awarded slots and qualifying IPF allocation. Revenue Cycle · due Oct 18, 2026
  2. Test cap and resident-time calculations against supporting cost-report records. Revenue Cycle · due Oct 25, 2026
  3. Validate rate and teaching-adjustment configuration with the operational owner. Compliance · due Nov 1, 2026
P2 CHANGED Operationally relevant Effective effective Oct 1, 2026

IRF October reminder separates clinical timing rules, corrected rates and later QRP deadlines

What changed

The codified rule requires therapy to begin within 36 hours from midnight on the day of admission. CMS illustrates this with a Tuesday 2 p.m. admission and a Thursday-noon deadline, and explains that the clock concerns therapies ordered during preadmission screening; new therapies ordered after that initial period are outside this requirement. The initial interdisciplinary meeting is due on or before four days from admission, followed by meetings at least weekly using seven consecutive calendar days.

The correction sets the conversion factor at $19,866 and outlier threshold at $8,856 without changing methodology. Separately, January 2027 data preparation supports FY 2029 QRP submissions and corrections by the fifteenth day of the second month after quarter-end, with calendar exceptions and the influenza deadline preserved. These reporting dates do not extend clinical clocks.

Why it matters
Admission-based clinical clocks require precise timestamps. Corrected payment values and a later reporting calendar create separate configuration tasks; neither extends the time allowed for patient care.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Quality, Revenue Cycle, IT

What to do nextAudit admission, therapy and meeting timestamps now; verify corrected rate tables and build the later QRP calendar separately. Playbook dates are recommended internal targets.

  1. Audit all admission-ordered therapy starts and initial/subsequent team-meeting timestamps. Clinical Operations · due Oct 18, 2026
  2. Verify corrected conversion and outlier values in payment tables. Revenue Cycle · due Oct 25, 2026
  3. Configure the later QRP submission calendar and test assessment/NHSN reconciliation. Quality · due Nov 1, 2026
P2 CARRYOVER Operationally relevant Final implementation Oct 5, 2026

Hospice FY 2027 payments and corrected aggregate impact estimate

What changed

The September 30 transmittal replaces R13924 and updates the FY 2027 tables following recalculation of hospice wage-index values for all CBSAs and rural areas. It applies to care furnished October 1, 2026 through September 30, 2027, with October 5 implementation. The ordinary payment update is 2.3 percent after the productivity adjustment; failure to meet quality-reporting requirements reduces that update by four percentage points to minus 1.7 percent. Actual payment also depends on the applicable level of care and geographic wage adjustment.

The Federal Register correction traces the recalculation to hospital wage data that had been wrongly excluded because an IPPS hospital was classified as a rural emergency hospital. It corrects national payment tables, quality-reporting alternatives, and the aggregate hospice impact table as part of the August final-rule framework. Separately, the transmittal sets the FY 2027 aggregate cap at $36,174.75 for the October-to-September cap year. That cap and the modeled aggregate impact are not a universal provider payment rate; rate-table reconciliation must retain the wage adjustment and reporting-status distinctions.

Why it matters
Budget estimates and claim payment rates are different measures. Conflating them would configure the wrong hospice rate.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Use the applicable wage-adjusted rate and quality-reporting adjustment; reconcile the replacement instructions and distinguish the aggregate impact estimate from the payment update.

What to do nextUse the applicable wage-adjusted rate and quality-reporting adjustment; reconcile the replacement instructions and distinguish the aggregate impact estimate from the payment update.

  1. Use the applicable wage-adjusted rate and quality-reporting adjustment; reconcile the replacement instructions and distinguish the aggregate impact estimate from the payment update. Revenue Cycle · due Oct 5, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Nov 2, 2026

CMS clarifies Medicare priority relative to FEHBP for federal annuitants receiving OWCP benefits

What changed

The October 2 transmittal takes effect and is implemented November 2. CMS responds to an OPM benefits-booklet position that treated Medicare as secondary to FEHBP for federal annuitants receiving OWCP benefits. The updated manual says Medicare is primary to FEHBP when the beneficiary maintains that coverage, receives federal workers' compensation, and is deemed unable to return to work after six months. The explanation turns on compensationer/annuitant status and absence of coverage by reason of current employment, rather than merely the receipt of an OWCP payment.

The same manual retains the general workers' compensation rule: Medicare may not pay to the extent payment has been made or can reasonably be expected under a workers' compensation law or plan. A Medicare payment for services payable under that system can constitute an overpayment, and the beneficiary must take necessary timely steps to obtain those benefits. The FEHBP comparison therefore does not erase the need to identify a liable workers' compensation payer for a particular item or service. Payer-order scripts should distinguish the employer-plan comparison from compensability and other MSP questions.

Why it matters
Registration and coordination-of-benefits logic can incorrectly equate OWCP benefit receipt with current employment or FEHBP primacy.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Patient Access
Affected functions
Patient Access, Revenue Cycle, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Review federal-annuitant payer-order scripts and refer unusual workers compensation claims for separate MSP analysis.

What to do nextReview federal-annuitant payer-order scripts and refer unusual workers compensation claims for separate MSP analysis.

  1. Review federal-annuitant payer-order scripts and refer unusual workers compensation claims for separate MSP analysis. Patient Access · due Nov 2, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Nov 2, 2026

Home health certification manual incorporates allowed practitioners

What changed

The September 30 transmittal updates Program Integrity Manual chapter 6 to reflect CARES Act section 3708, with November 2 effectiveness and implementation. The revised manual recognizes physician assistants, nurse practitioners, and clinical nurse specialists as allowed practitioners for home-health certification and recertification. It retains homebound, skilled-care, plan-of-care, and face-to-face conditions. Failure to substantiate initial certification can also defeat later episodes even when recertification requirements are met, so accepting an allowed practitioner does not dispense with the underlying eligibility record.

The certifying practitioner's or qualifying acute/post-acute facility's record can establish eligibility, either alone or with appropriately incorporated agency documentation. Agency-generated records by themselves are insufficient. Supporting HHA material must be signed off and incorporated into the practitioner or facility record, corroborate the rest of the clinical record, and correspond to the billed dates. The manual treats incorporation as timely when signed off before or at claim submission. Its review approach therefore examines a consistent combined record, rather than accepting a stand-alone agency certification packet or rejecting valid records solely because an allowed practitioner supplied them.

Why it matters
Admission and certification controls should not reject valid allowed-practitioner records or relax the remaining homebound, skilled-care and face-to-face requirements.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Provider Enrollment
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Validate certification templates, practitioner credentials and supporting medical records against the revised manual while preserving all other eligibility requirements.

What to do nextValidate certification templates, practitioner credentials and supporting medical records against the revised manual while preserving all other eligibility requirements.

  1. Validate certification templates, practitioner credentials and supporting medical records against the revised manual while preserving all other eligibility requirements. Clinical Operations · due Nov 2, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final implementation Oct 30, 2026

Medicare EDI manual supports the TCEDI gateway

What changed

The September 29 transmittal revises Claims Processing Manual chapter 24 to support Technical Consolidation of Electronic Data Interchange, with October 30 effectiveness and implementation. Where CMS designates TCEDI, it may generate or coordinate intake acknowledgments before shared-system processing. The manual distinguishes TA1 or 999 rejection of an entire transaction set from errors passed to the common editing module for claim-level 277CA acknowledgment. A 999 accepted-with-errors response is therefore a different processing state from an unqualified acceptance or a paid claim.

The common editing module reports erroneous 837 claim data through 277CA and erroneous 276 claim-status data through a 277 response. The manual also addresses outbound compliance and balancing checks. Transactions rejected or returned as unprocessable are not treated as received by Medicare, and contractors need not assign them a receipt date or control number under the stated rule. Receipt dates for accepted claims must reflect actual calendar receipt rather than later shared-system arrival. These instructions support acknowledgment reconciliation and escalation; the transmittal does not itself state one universal provider migration deadline.

Why it matters
Clearinghouse and trading-partner workflows need to reconcile gateway references and acknowledgement handling against contractor guidance.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
IT
Affected functions
IT, Revenue Cycle, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Review the revised EDI manual with the clearinghouse and MAC. Test applicable acknowledgements and escalation contacts; do not infer an unsupported provider migration deadline from the manual revision.

What to do nextReview the revised EDI manual with the clearinghouse and MAC. Test applicable acknowledgements and escalation contacts; do not infer an unsupported provider migration deadline from the manual revision.

  1. Review the revised EDI manual with the clearinghouse and MAC. Test applicable acknowledgements and escalation contacts; do not infer an unsupported provider migration deadline from the manual revision. IT · due Oct 30, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Jan 1, 2027

January 2027 home health grouper uses version 08.0.27

What changed

The September 30 transmittal makes version 08.0.27 applicable to claim From dates on or after January 1, 2027. Its business requirement covers type-of-bill 032x claims other than 32A and 320, while the implementation date is January 4. Those two dates perform different functions: the service-period selection determines which grouper applies, and the implementation date directs the contractor release. A claim submitted later should not automatically be assigned the new version solely because it arrived after installation.

CMS explains that the grouper assigns a Home Health Resource Group using claim and patient-assessment information, including diagnoses. Annual ICD-10-CM changes and quarterly changes in case-mix policy or diagnosis codes can require updated software; the transmittal distinguishes this January release from the October update under CR 14509. CMS links the grouper package and supporting documentation separately. Version selection and test cases should therefore preserve the claim From-date boundary and excluded bill types, rather than treating a vendor installation confirmation as proof that every assessment and claim grouped correctly.

Why it matters
Home health grouping software and assessment inputs need coordinated testing before January claims.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
IT
Affected functions
IT, Coding, Revenue Cycle, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Schedule vendor installation and regression checks for claim From dates straddling January 1, and reconcile grouping to CMS documentation.

What to do nextSchedule vendor installation and regression checks for claim From dates straddling January 1, and reconcile grouping to CMS documentation.

  1. Schedule vendor installation and regression checks for claim From dates straddling January 1, and reconcile grouping to CMS documentation. IT · due Jan 1, 2027
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Jan 1, 2027

CMS issues January ASP, MPFS and ZIP-code system update instructions

What changed

The September 29 ASP and MPFS transmittals use January 1, 2027 effectiveness and January 4 implementation. ASP instructions address current and revised prior-quarter drug files, separately distinguish OPPS processing, and direct contractors not to search previously processed claims unless brought to their attention. MPFS instructions anticipate datasets, including anesthesia conversion factors, around final-rule display in November and require readiness for up to three replacement datasets if corrections are needed. Those conditional replacements are not proof that three corrections have already been issued.

The ZIP instruction covers ZIP5 and ZIP9 files, including 2026 calendar-year-end files for the January quarter. Its effective dates are January 1, April 1, July 1, and October 1, with implementation January 4, April 5, July 5, and October 4. Contractors retrieve notified files into testing and production; ZIP5 supports ambulance pricing and other uses where directed. CMS warns even the latest file may omit ZIP codes created after compilation, requiring the manual's separate handling. These reference releases support payment processing without independently finalizing every underlying rate or coverage policy.

Why it matters
Different reference files feed drug payment, professional claims and geographic payment logic. A successful load requires coordinated vendor testing.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
IT
Affected functions
IT, Revenue Cycle, Coding, Finance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Inventory the three releases and test the first January implementation. Monitor subsequent corrections and the applicable final payment policies separately.

What to do nextInventory the three releases and test the first January implementation. Monitor subsequent corrections and the applicable final payment policies separately.

  1. Inventory the three releases and test the first January implementation. Monitor subsequent corrections and the applicable final payment policies separately. IT · due Jan 1, 2027
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final

Acute Hospital Care at Home telehealth billing uses hospital POS 21

What changed

The October 1 newsletter instructs providers delivering telehealth to patients enrolled in Acute Hospital Care at Home to use place of service 21, inpatient hospital, and modifier 95 for synchronous telemedicine. CMS explains that these patients remain inpatients even when care is delivered at home. The instruction is specific to that enrolled hospital setting; it does not classify every home-based telehealth encounter as inpatient or establish a new ordinary home-telehealth billing rule.

Why it matters
An inpatient at-home care location does not itself change the Medicare claim to an outpatient home telehealth service.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Validate AHCAH charge mapping, professional billing interfaces and payer-specific claim edits with the hospital billing team.

What to do nextValidate AHCAH charge mapping, professional billing interfaces and payer-specific claim edits with the hospital billing team.

  1. Validate AHCAH charge mapping, professional billing interfaces and payer-specific claim edits with the hospital billing team. Revenue Cycle · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final

Short-term acute care PEPPER report is available through CMS identity controls

What changed

The October 1 newsletter announces the second-quarter FY 2026 Program for Evaluating Payment Patterns Electronic Report for short-term acute-care hospitals. CMS describes using the report to review billing data, identify patterns needing review, flag possible undercoding or overcoding, monitor risk, and examine trends such as longer stays. These are uses for focused internal analysis. A billing-pattern signal alone does not establish that a particular claim is improper or that an organization owes a repayment.

Authorized officials, access managers, and staff end users can download their own organization's report from the PEPPER Portal. Staff users request the PEPPER business function through CMS Identity and Access, and an authorized official or access manager must approve that access. CMS also describes requesting the Comparative Billing Report function at the same time and supplies training and assistance links. Access authorization therefore needs to precede facility-specific analysis; the public availability notice is neither the hospital's private report nor an attestation that its results have been reviewed.

Why it matters
PEPPER is a prospective audit signal, not an audit determination or repayment demand. Hospital outliers can inform a focused internal review.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Compliance
Affected functions
Compliance, HIM/CDI, Revenue Cycle
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Confirm authorized report access, review hospital-specific outlier areas and choose documentation samples with Compliance.

What to do nextConfirm authorized report access, review hospital-specific outlier areas and choose documentation samples with Compliance.

  1. Confirm authorized report access, review hospital-specific outlier areas and choose documentation samples with Compliance. Compliance · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final implementation Oct 31, 2026

Refugee medical assistance period corrected to twelve months

What changed

The October 1 correction addresses a July 14 notice that had extended the eligibility period for Refugee Cash Assistance and Refugee Medical Assistance. After reviewing the considerations in 45 CFR 400.211, ORR changes the stated period from eight to twelve months for both programs. It directs correction of the summary and three specified supplementary-information paragraphs, so the corrected duration is not limited to medical assistance while leaving the cash-assistance period at eight months.

The date provision says recipients should implement the change within thirty days of Federal Register publication, consistent with 45 CFR 400.211(b). October 31 is the corresponding thirty-day implementation target used here. The short correction does not decide an individual's eligibility or reproduce state case-processing and outreach procedures. Eligibility teams therefore need to apply the corrected assistance-program duration to relevant cases while separately checking state implementation and the other requirements governing those cases, rather than promising twelve months of Medicaid to every person with refugee status.

Why it matters
Eligibility teams must distinguish assistance programs and avoid applying the erroneous duration to affected cases.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Patient Access
Affected functions
Patient Access, Case Management, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Review applicable refugee medical assistance cases and reconcile state implementation and outreach instructions before changing eligibility workflows.

What to do nextReview applicable refugee medical assistance cases and reconcile state implementation and outreach instructions before changing eligibility workflows.

  1. Review applicable refugee medical assistance cases and reconcile state implementation and outreach instructions before changing eligibility workflows. Patient Access · due Oct 31, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Oct 1, 2026

SNF FY 2027 correction revises wage-index calculations and burden estimates

What changed

The September 30 correction restores hospital wage data wrongly excluded when an IPPS hospital was classified as a rural emergency hospital. That restoration requires recalculation of the SNF wage-index budget-neutrality factor, unadjusted federal per diem rates, case-mix-adjusted rates, and related PDPM and wage-adjustment examples. CMS says the impact analysis in Table 25 is unaffected at the displayed precision. The correction is effective October 1 as part of the final-rule framework; its financial effect still depends on the applicable corrected tables and facility wage adjustment.

The separate SNF Quality Reporting Program error concerns use of mean rather than median Bureau of Labor Statistics wages in burden calculations. Correcting those wage assumptions changes reported burden estimates, rather than establishing that every facility experienced that amount of actual administrative cost. CMS characterizes the document as correcting technical and typographical errors without substantive changes to adopted policy or payment methodology. Rate-table reconciliation and review of the corrected burden discussion are therefore distinct tasks, and neither supports applying one new universal percentage to every SNF claim.

Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Reconcile the affected FY 2027 SNF rate tables and wage-index calculations against the corrected publication.

What to do nextReconcile the affected FY 2027 SNF rate tables and wage-index calculations against the corrected publication.

  1. Reconcile the affected FY 2027 SNF rate tables and wage-index calculations against the corrected publication. Revenue Cycle · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final

California IRF ownership changes require correct RCD selections and new identifiers

What changed

The September 28 notice says the existing provider agreement is assigned to the new owner unless assignment is rejected. A rejecting buyer must complete the new-provider process and enters the target affirmation-rate review cycle applicable when enrollment is finalized. An accepting buyer continues the current RCD option and inherits reviews and affirmation decisions from the ongoing cycle; those results affect choices in the next selection period. Buyer and seller should coordinate any selection period occurring before the ownership change is finalized.

After finalization, the notice directs establishment of portal access using the buyer's applicable CCN/NPI combination and new tracking requests with updated identifiers. A UTN linked to an NPI different from the claim NPI causes return to provider. For a pre-finalization tracking request needing an NPI update, Noridian directs contact with the Provider Contact Center. Administrators must also authorize staff for pre-claim review and related functions. These steps distinguish continuity of a review-cycle choice from continuity of portal access and claim identifiers; inherited affirmation history alone does not resolve an identifier mismatch.

Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextCoordinate the CHOW with Noridian before finalization; document assignment acceptance, cycle choice and affirmation history, and validate new CCN/NPI/UTN combinations on claims.

  1. Include RCD selections, prior affirmation rates, portal permissions and UTN/NPI continuity in IRF acquisition and enrollment checklists. Revenue Cycle · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Final effective Oct 1, 2026

Noridian October coding updates change FFR, infusion-pump and SAD billing

What changed

The October 1 coding notice adds 1086T, 1087T, and 1104T to A58095 for non-invasive fractional flow reserve. A55239 revision 27 separately updates Prialt and ropivacaine pricing for October through December, while A53032 revision 48 removes J1941 from its excluded-code list. Another notice updates article-specific ICD-10 tables. These are different coding, pricing, and exclusion changes, rather than a single new coverage benefit or permission to apply a price without checking the service date, drug unit, and applicable article.

A58095 requires the referring/ordering physician's name and NPI and clinical/CCTA information supporting the post-imaging FFR analysis, including the analysis report. A55239 retains medical-necessity conditions, unsuccessful less-invasive treatment, specialist evaluation, and a documented preliminary intrathecal or epidural trial. A53032 continues route-specific JA/JB rules for marked drugs with multiple administration routes, including medical necessity of the route and denial consequences for missing required modifiers. A revised code or removal from the exclusion table therefore does not dispense with the remaining clinical, benefit, and billing conditions.

Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextUpdate affected code and price tables and validate billing against each complete policy and benefit rule.

  1. Update affected code and price tables and validate billing against each complete policy and benefit rule. Revenue Cycle · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P2 CARRYOVER Operationally relevant Effective

Medi-Cal updates maintenance dialysis billing for restricted-scope members

What changed

For service dates on or after October 1, the notice covers maintenance dialysis and transportation to and from dialysis clinics as state-only benefits for members with unsatisfactory immigration status enrolled in restricted-scope aid codes, regardless of age. The policy is defined by those eligibility and service conditions. It expressly leaves dialysis meeting the federal emergency-medical-condition definition unchanged, so the state-only maintenance provision should not be treated as a replacement for emergency coverage rules.

Providers may hold dialysis and transportation claims until system changes are fully implemented. Alternatively, DHCS says it will use an Erroneous Payment Correction to reprocess qualifying claims automatically for October 1 and later service dates. Providers need take no action for claims qualifying for that correction unless later communications instruct otherwise. The notice promises additional information after system updates; it does not demonstrate that the update or payment is complete. Claim tracking therefore needs to distinguish optional holding from qualifying automatic reprocessing, without generating unnecessary duplicate submissions.

Why it matters
Submitting unnecessary duplicates can delay reimbursement while eligibility and payment logic are changing.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Patient Access, Clinical Operations, Managed Care
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextIdentify affected dialysis and transportation claims, verify aid codes and follow DHCS hold or reprocessing instructions. Do not resubmit automatically.

  1. Identify restricted-scope maintenance dialysis and transportation claims with October 1 and later service dates. Revenue Cycle · due Oct 18, 2026
  2. Confirm eligibility and aid-code treatment without changing emergency dialysis access. Patient Access · due Oct 18, 2026
  3. Track system updates and EPC outcomes; prevent duplicate resubmission absent a DHCS instruction. Clinical Operations · due Oct 18, 2026
P2 CARRYOVER Operationally relevant Effective compliance Nov 29, 2026

RHC and FQHC timeliness waiver opens for eligible LMFT and psychological associate claims

What changed

The September 29 notice expressly closes the window November 29. It covers services from January 1, 2025 by registered psychological associates supervised by licensed clinical psychologists. Held LMFT claims qualify when unpaid under another billable service because the change-in-scope request requirement was eliminated under SPA 25-0009. Services must still satisfy PPS coverage, billing, and practitioner scope requirements; the waiver does not reopen every unpaid encounter.

Use revenue code 0521 with T1015 or T1015 SE. For dual-eligible members outside Medi-Cal managed care, the notice specifies revenue 900 or 529 with G0469 or G0470. Include a clinically appropriate diagnosis and informational-line procedure. Box 80 remarks must identify “Timeliness Waiver for Psychological Associate” or “Timeliness Waiver for LMFT.” Associate claims require the supervising clinical psychologist’s NPI and applicable supervision/documentation. Duplicates, incorrect codes or practitioner identification, and claims where a medical or mental-health service was previously adjudicated for the same member that day are ineligible.

Why it matters
A limited filing window can recover eligible held claims but does not permit duplicate payment or unsupported services.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextReview eligible unpaid claims, apply the notice billing codes and exact waiver remarks, supply supervising psychologist NPI where required and submit by the stated November 29 date.

  1. Inventory eligible unpaid January 1, 2025 and later encounters and exclude previously adjudicated same-day applicable claims. Revenue Cycle · due Oct 18, 2026
  2. Confirm supervision, rendering documentation and the specified T1015 or Medicare crossover code combination. Coding · due Oct 18, 2026
  3. Use the exact Psychological Associate or LMFT timeliness-waiver remarks and submit eligible claims by November 29. Clinical Operations · due Nov 29, 2026
P2 CHANGED Operationally relevant Announced

DOJ corporate fraud directive expands healthcare program-integrity targeting signals

What changed

Directive 26-12, dated October 1, identifies healthcare among corporate fraud priorities and directs prosecutors to apply established corporate-prosecution and voluntary-disclosure policies. It emphasizes accountability while guarding against overbroad enforcement and crediting disclosure, cooperation, and remediation. That context matters when evaluating the later methods directive; neither document establishes that a particular healthcare organization committed misconduct.

Directive 26-13 directs assessment of appropriate tax, securities, consumer, and other charges alongside fraud theories. It emphasizes early recovery of proceeds and legally available injunctions or seizures, including digital infrastructure used in schemes. Its guidance applies to prosecutors and disclaims creation of enforceable private rights. Compliance preservation and affiliate-control review are internal readiness recommendations, rather than new statutory duties or proof that a specific provider faces investigation.

Why it matters
The directive expressly includes healthcare fraud and instructs prosecutors on tax, securities and consumer charges. It governs prosecutor methods; it establishes no new provider implementation deadline.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Compliance
Affected functions
Compliance, Legal, Executive Leadership, Revenue Cycle

What to do nextCounsel and compliance should align preservation, billing-integrity and affiliate controls with potential cross-program investigations. These are recommended internal readiness steps.

  1. Brief compliance leadership on the corporate fraud priorities and escalation triggers. Compliance · due Oct 18, 2026
  2. Reconcile billing-outlier monitoring with clinical and enrollment controls. Legal · due Oct 18, 2026
  3. Review existing resolution requirements and voluntary-disclosure considerations with counsel, without treating the DOJ internal seven-day deadline as a provider duty. Executive Leadership · due Oct 18, 2026
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

SB 1049 gives qualifying claim corrections a minimum filing period

What changed

The new parallel plan and insurer sections apply when a claim denial, partial denial, or overpayment notice rests wholly or partly on a defect that can be fixed through a corrected claim. The claimant receives no less than ninety calendar days from the carrier's most recent action to submit the correction. That trigger is the relevant carrier action, rather than automatically the original service date or the date of the first rejection in a longer claim history.

A qualifying correction filed within that period cannot be denied for missing another otherwise applicable claim-filing deadline. Related disputes must be eligible for the carrier's dispute-resolution mechanism. The act also authorizes department guidance and necessary regulations, including consistent DHCS guidance under the plan provision. These safeguards preserve a route to correct and dispute an eligible defect; they do not establish that the corrected claim is medically necessary, covered, or automatically payable on its merits.

Why it matters
Appeals and corrections workflows must distinguish eligible defects and notification dates.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Managed Care, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map covered corrections, trigger dates and submission evidence; update work queues and payer communications. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextMap covered corrections, trigger dates and submission evidence; update work queues and payer communications.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Revenue Cycle · due Oct 18, 2026
  2. Map covered corrections, trigger dates and submission evidence; update work queues and payer communications. Managed Care · due Nov 15, 2026
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1629 changes noncontracted dental assignment of benefits

What changed

A plan or insurer covering out-of-network dental services must pay the noncontracting provider directly when a compliant assignment of benefits is submitted. The provider definition includes registered dental hygienists in alternative practice. The payment remains governed by the member's covered benefit; the assignment does not itself add an out-of-network benefit or guarantee that a proposed treatment is covered. The plan section excludes Medi-Cal managed care contracts, including dental managed care.

Before obtaining assignment, the provider must disclose noncontracted status, potentially lower in-network costs, estimated treatment and member costs, possible coverage limits, and the member's right to confirm benefits. Assignment is optional and may be revoked in writing for services not yet rendered. Signed, dated consent must be retained, although it need not accompany the assignment when that record is maintained. Before carrier payment, the provider may collect only estimated cost sharing or an approximating deposit. Payment-routing changes therefore require consent and collection controls alongside claim submission.

Why it matters
Dental billing teams need accurate consent and reimbursement workflows.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Patient Access, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Review assignment documents, estimate disclosures and payment handling before applying the new pathway. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextReview assignment documents, estimate disclosures and payment handling before applying the new pathway.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Revenue Cycle · due Oct 18, 2026
  2. Review assignment documents, estimate disclosures and payment handling before applying the new pathway. Patient Access · due Nov 15, 2026
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

SB 950 adds qualifying dementia treatment coverage protections

What changed

Contracts or policies issued, amended, or renewed from January 1, 2027 must cover medically necessary FDA-approved treatments for Alzheimer's disease or other memory conditions, as determined by a health care provider. The provision reaches medical benefits and prescription-drug benefits to the extent the contract provides them. Its step-therapy restriction addresses both self-administered and physician-administered drugs, but does not require all treatment types to be available without step therapy when at least one antiamyloid therapy is covered without it.

Other utilization management, including prior authorization, remains available when medical necessity and appropriateness are assessed in the same manner as for other covered conditions. Criteria cannot be more restrictive than FDA-approved indications, and authorization for medically necessary covered treatment is treated as an exigent circumstance. The plan provision excludes Medi-Cal managed care, dental-only or vision-only specialized contracts, and Medicare supplements; the insurance section also lists specified limited-benefit exclusions. These conditions call for product- and contract-specific configuration rather than removing every dementia utilization edit.

Why it matters
Commercial pharmacy and neurology workflows need product-specific benefit configuration.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm covered contracts, FDA criteria and antiamyloid access; retain lawful review and member-specific medical necessity. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextConfirm covered contracts, FDA criteria and antiamyloid access; retain lawful review and member-specific medical necessity.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Confirm covered contracts, FDA criteria and antiamyloid access; retain lawful review and member-specific medical necessity. Compliance · due Jan 1, 2027
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1843 limits prior authorization for covered hepatitis C antivirals

What changed

The parallel plan and insurer provisions prohibit prior authorization for direct-acting antiviral drugs medically necessary to treat hepatitis C, subject to the stated exception. The protected category is defined by drug function and medical necessity. It is not a repeal of every pharmacy review or a direction to treat all drugs used by a patient with hepatitis C as interchangeable antivirals.

When FDA-approved therapeutic equivalents of a pangenotypic drug, device, or product exist, the law does not require all equivalent versions to bypass authorization if at least one pangenotypic, therapeutically equivalent version is covered without it. The plan section expressly excludes Medi-Cal managed care contracts. A formulary or dispensing review therefore needs to identify the qualifying no-authorization option and the member's product, rather than either retaining authorization on every equivalent or removing it from unrelated treatments.

Why it matters
Pharmacy and specialty treatment access depend on correctly scoped benefit edits.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Identify affected products and statutory scope, revise qualifying prior authorization edits and validate dispensing and claims workflows. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextIdentify affected products and statutory scope, revise qualifying prior authorization edits and validate dispensing and claims workflows.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Identify affected products and statutory scope, revise qualifying prior authorization edits and validate dispensing and claims workflows. Compliance · due Nov 15, 2026
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1887 sets rare disease drug authorization timing

What changed

For contracts or policies issued, amended, or renewed from January 1, 2027, the rule applies when the drug is the only FDA-approved treatment for a rare disease, is prescribed by a specialist with relevant expertise, and is determined medically necessary by that specialist. The act defines rare disease as affecting fewer than 200,000 people in the United States. An initial request occurs when the provider or staff sends authorization to the carrier or its delegate, making that transmission evidence material to the clock.

Authorization must be completed within thirty days. Immediate approval is required if no approval or denial decision exists at the end of the period, or if a dispute with the provider or member remains ongoing then. The act preserves the separately referenced authorization timelines, including faster applicable processes, rather than granting thirty days for every case. Medi-Cal managed care is excluded from the plan provision. Request tracking must therefore retain both the qualifying clinical conditions and the actual initial transmission, without treating any expensive specialty drug as automatically within this pathway.

Why it matters
Specialty pathways need timely expert documentation and request tracking.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm covered drugs, prescriber expertise and required request content; monitor response timing and escalate delays. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextConfirm covered drugs, prescriber expertise and required request content; monitor response timing and escalate delays.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Confirm covered drugs, prescriber expertise and required request content; monitor response timing and escalate delays. Compliance · due Jan 1, 2027
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

SB 964 creates a qualifying drug dose adjustment request pathway

What changed

A written request may seek authority to adjust dose or frequency to the member's medical needs without further prior authorization or utilization management. The carrier must respond in writing within seventy-two hours of receipt and authorize when the request establishes prior coverage for the member's serious chronic condition or cancer, continued prescribing for that condition, exclusion of opioids and scheduled controlled substances, and the limit on earlier adjustments. The provision specifically uses a treating contracting provider, rather than any person asking to change a prescription.

The statutory limit is that the dose has not already been adjusted more than twice without prior authorization. For an off-label drug or adjusted use, the separate referenced coverage conditions must also be satisfied. Medi-Cal managed care is excluded from the plan section. These gates support a documented pathway for qualifying ongoing treatment, but do not establish automatic approval from carrier silence, eliminate every future review of an unqualified adjustment, or authorize changes outside the prescribing clinician's responsibility.

Why it matters
This pathway can reduce repeat review but is not a universal prior authorization repeal.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Create a qualifying request template, document each condition and track written responses for covered commercial products. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextCreate a qualifying request template, document each condition and track written responses for covered commercial products.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Create a qualifying request template, document each condition and track written responses for covered commercial products. Compliance · due Nov 15, 2026
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final implementation Jan 15, 2027

SB 1094 changes biosimilar substitution and formulary requirements

What changed

A pharmacist may select a qualifying biosimilar as well as an interchangeable biological product, subject to a prescriber's no-substitution direction and a patient cost no higher than the prescribed product. The law retains patient notice and prescriber communication, including the specified five-day electronic-record route and alternatives. Separately, qualifying prescription-drug contracts issued, amended, or renewed from January 1, 2027 must list a qualifying alternative when the reference product is on the formulary and the alternative has a lower net cost to the carrier. Dispensing authority and formulary inclusion are therefore different decisions.

A carrier-directed switch must meet net-cost and member-cost-sharing conditions and provide at least sixty days' notice with identified alternatives, affected members, and applicable formulary or step-therapy exception instructions. An existing reference-product authorization does not require a new authorization for the alternative, and the act restricts affiliated-product-only requirements when unaffiliated biosimilars are available. Provider notices about listed reference/alternative products are due January 15, 2027, while reporting starts by October 1. These mechanisms preserve prescriber no-substitution and member exception routes rather than giving the carrier authority to rewrite a prescription.

Why it matters
Pharmacy and benefit teams need consistent substitution and continuity rules.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Reconcile dispensing authority, prescriber instructions, formulary selection and member continuity exceptions. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextReconcile dispensing authority, prescriber instructions, formulary selection and member continuity exceptions.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Reconcile dispensing authority, prescriber instructions, formulary selection and member continuity exceptions. Compliance · due Jan 1, 2027
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 1906 adds qualifying cervical screening home test coverage

What changed

Commercial contracts or policies issued, amended, or renewed from January 1, 2027 must cover cervical screening ordered or provided by an in-network practitioner within scope and consistent with the referenced recommendations. The covered test category includes FDA-authorized or cleared kits permitting self-collection outside a clinical setting. The commercial cost-sharing prohibition retains the HSA-eligible high-deductible qualification and excludes specified limited benefits; the plan provision separately excludes Medi-Cal managed care. A home location alone does not qualify an unapproved kit or dispense with the ordering conditions.

The separate Medi-Cal benefit begins January 1 for qualifying kits ordered or provided by the member's practitioner, consistent with recommendations and Medi-Cal policy. It applies to both fee-for-service and managed care and bars beneficiary cost sharing, including the described share-of-cost or spenddown treatment. Appropriate billing codes, medical necessity, and federally permitted utilization controls remain. Coverage is conditioned on available federal participation, no jeopardy to that participation, and necessary approvals. DHCS may implement through letters or bulletins, so the statutory benefit and the ensuing operational instructions need separate tracking.

Why it matters
Member access and claims workflows must distinguish approved kits and applicable delivery systems.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm order, network and kit requirements and benefit edits; track separate Medi-Cal implementation guidance. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextConfirm order, network and kit requirements and benefit edits; track separate Medi-Cal implementation guidance.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Managed Care · due Oct 18, 2026
  2. Confirm order, network and kit requirements and benefit edits; track separate Medi-Cal implementation guidance. Compliance · due Jan 1, 2027
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Jan 1, 2027
P2 CARRYOVER Potentially applicable Final effective Jan 1, 2027

AB 2348 revises Medi-Cal enhanced care management implementation

What changed

ECM remains a managed-care benefit under a comprehensive risk contract for eligible target populations, with exclusions for specified overlapping high-intensity services and integrated dual-eligible programs. The act preserves nonduplication and collaboration with behavioral-health delivery systems. Community supports remain alternative services and settings that plans may offer under the applicable authority. DHCS must maintain sufficiently detailed model guidance, publish plan offerings and utilization information, and provide implementation support; plans must align policies and educate their contracted providers.

Regular community-support guide changes require at least two weeks for public input, written release at least six months before effectiveness, and a January 1 or July 1 effective date. DHCS may depart from that process when needed for effective delivery, but must notify stakeholders and explain why. By March 31, 2029, DHCS must give the Legislature information on possible transition to required benefits, drawing on the CalAIM evaluation. That reporting duty supports later consideration rather than itself making the conversion or erasing current eligibility, contract, and nonduplication boundaries.

Why it matters
Managed care and care management teams need alignment with DHCS operational guidance.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Case Management
Affected functions
Case Management, Managed Care, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map existing ECM and community support workflows to the final provisions and subsequent DHCS instructions; validate training and plan reporting responsibilities. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.

What to do nextMap existing ECM and community support workflows to the final provisions and subsequent DHCS instructions; validate training and plan reporting responsibilities.

  1. Confirm affected members, benefits and contracts against the final statutory scope. Case Management · due Oct 18, 2026
  2. Map existing ECM and community support workflows to the final provisions and subsequent DHCS instructions; validate training and plan reporting responsibilities. Managed Care · due Nov 15, 2026
  3. Validate updated workflows, communicate changes and monitor implementing guidance. Compliance · due Dec 15, 2026
P2 CARRYOVER Potentially applicable Final implementation Jul 1, 2027

SB 874 requires BHT employee background checks and stakeholder-informed policy

What changed

By July 1, 2027, DHCS must ensure that enrolled Medi-Cal entities providing program-paid BHT arrange state and national criminal background checks for employees who interact with patients, either directly or through a third party. Providers must retain compliance documentation and make it available on request or audit. The screening clause is not limited to a future stakeholder recommendation, and the statute does not make a blanket fingerprint method the condition for every check.

The stakeholder process addresses clinical assessment, treatment plans, service settings, supervision, credentialing, contracting quality, and feasibility of fingerprint-based checks. DHCS must maintain clear coverage and billing guidance consistent with EPSDT for people under twenty-one. By January 1, 2029 it must publish utilization data and a policy synopsis identifying feedback-driven changes and any needed program-integrity actions. These policy and publication duties complement the employee-check and recordkeeping requirement; participation in a forum alone does not demonstrate compliance with screening.

Why it matters
Patient-facing BHT employee screening needs documented state and national checks and auditable records. HR, clinical leadership and contracted-provider oversight should align hiring and retention controls with forthcoming DHCS implementation; participation in stakeholder work does not replace the enacted background-check duty.
Response type
Assess
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Managed Care, Revenue Cycle, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Track DHCS forums and billing guidance and compare resulting changes with current provider controls. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
Long lead justification
The July 1, 2027 statewide implementation requires employee and contracted-entity inventories, state and national screening processes and auditable records. Early HR and provider-oversight preparation is justified despite the deadline exceeding 180 days; no human approval is claimed. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextAssign BHT compliance and HR to document state and national checks for patient-facing employees before July 1, 2027; track DHCS implementation and retain evidence for audit.

  1. Coordinate with HR to inventory patient-facing BHT employees and contracted entities; compare current state and national checks and record-retention controls. Internal preparation target. Compliance · due Oct 25, 2026
  2. Assign a DHCS implementation monitor and document responsibility for auditable screening evidence and provider oversight. Internal preparation target. Compliance · due Oct 25, 2026
  3. Reconcile issued DHCS instructions with screening procedures and close documented gaps before the statutory implementation milestone. Clinical Operations · due Jul 1, 2027
P2 NEW Directly applicable Final implementation Jan 1, 2027

DHCS specifies BHSA service claiming codes for January 2027

What changed

From January 1, 2027 service dates, county behavioral health plans must identify covered EBP, other Full Service Partnership, and early-intervention services using BHIN 26-031. Plans may elect monthly bundles for ACT, FACT, coordinated specialty care, and IPS supported employment using H0040, H0039, H2040, and H2023 respectively. Their corresponding unbundled pathways use appropriate service codes with WJ, WK, WC, and WD. Bundled ACT and FACT require prior authorization; their unbundled pathways do not. The notice also preserves a specified additional unbundled-claim pathway for opted-in ACT/FACT members receiving at least 12 services monthly.

Every BHP must claim High Fidelity Wraparound monthly with H2022, with no unbundled alternative. Other FSP and early-intervention identifiers apply to all BHPs: WI for intensive care management, WA for assertive field-based SUD initiation, WF for other FSP, HX for early-intervention EBPs/CDEPs, and WB for other early intervention, paired with the appropriate service families. These modifiers support tracking and reporting without changing adjudication. Housing interventions are outside Short Doyle SMHS/DMC/DMC-ODS claiming. The notice retains a BHIN 26-XXX placeholder and anticipates further HFW coverage guidance, so the existing monthly requirement should be implemented without treating that future guidance as already issued.

Why it matters
Tracking modifiers support performance measurement and do not affect adjudication. HFW requires monthly bundled claiming; forthcoming HFW guidance remains a dependency. Housing interventions are not claimed as SMHS, DMC or DMC-ODS through Short Doyle.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations, IT, Managed Care

What to do nextMap bundled and unbundled services separately and test the notice's exact table with county partners. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Map EBP, other FSP and EI services to the specified claiming table with county partners. Coding · due Oct 25, 2026
  2. Test bundled versus unbundled claim examples and tracking modifiers in the claims system. IT · due Nov 15, 2026
  3. Confirm HFW guidance dependencies and keep housing costs outside Short Doyle clinical claims. Revenue Cycle · due Dec 15, 2026
P2 NEW Directly applicable Final compliance Jul 9, 2027

HCBS compensation reporting guidance separates 2027 readiness from 2028 reports

What changed

States must email CMS by July 9, 2027 describing readiness to collect direct-care compensation data. The requirement covers specified HCBS authorities under sections 1915 and 1115, with stated exceptions, and excludes section 1905(a) services. Fee-for-service applicability begins July 9, 2028; managed care begins with the first contract rating period starting on or after that date. These are different implementation gates, not one simultaneous provider filing deadline.

CMS expects an annual reporting window around September 1 through December 31 beginning in 2028, measuring the preceding calendar year. Thus the first 2028 report concerns provider payments during 2027. The anticipated collection form remains subject to PRA review. States retain responsibility for collecting data and may involve providers and managed-care plans. Readiness work therefore needs authority-specific data ownership and state instructions, rather than one assumed filing date for every provider.

Why it matters
The guidance reaches specified 1915 and 1115 HCBS authorities in fee-for-service and managed care. It excludes the section 1905(a) personal care, home health and case management benefits. It does not make the separate 80 percent compensation rule immediately operative.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Managed Care, Clinical Operations, Compliance
Long lead justification
The newly issued state guidance requires compensation data and managed-care contract preparation before July 2027 readiness reporting; provider data dependencies warrant early planning beyond the 180-day horizon. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextMap service authorities and data owners now; validate provider compensation data and managed-care reporting contracts against state instructions. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Identify HCBS service authorities and provider populations covered by compensation reporting. Managed Care · due Oct 25, 2026
  2. Inventory compensation and payment data sources and document gaps in contractor reporting. Finance · due Nov 15, 2026
  3. Establish a state-guidance dependency and test representative reporting data before scaling. Compliance · due Dec 15, 2026
P2 NEW Directly applicable Final implementation Apr 5, 2027

Medicare SNF place of service utility will reprocess overlapping claims

What changed

CMS transmittal 13995, dated October 8, 2026, directs a one-time claims utility under CR 14582. Effective April 1, 2027, with April 5 implementation, it identifies professional claim lines using place-of-service code 32 for May 11, 2023 through December 31, 2024 when their dates overlap a posted Part A SNF or swing-bed claim. Critical access hospital swing-bed claims are excluded. Contractors must reprocess claims flagged by informational response 7303 and follow standard recoupment procedures for resulting overpayments.

The underlying distinction matters because POS 31 applies during Part A-covered SNF stays, while POS 32 covers nursing facilities and SNF stays without Part A coverage. In mixed facilities, CMS requires POS 31 unless the physician verifies no Part A payment will be made. Organizations should match potentially affected professional claims to actual covered-stay records before reconciling adjustments. The instruction assigns the historical search to contractors; it does not tell every provider to rebill all nursing-facility services.

Why it matters
POS 31 reflects Part A covered SNF stays, while POS 32 reflects nursing facilities or noncovered SNF stays. Reprocessing can create recoupments. The actual PDF identifies CR 14582, while its landing-page reference differs.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Finance, Compliance

What to do nextPreserve the PDF identifier discrepancy and inventory potentially affected professional claims before MAC adjustments. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Identify POS 32 professional claims for May 11, 2023 through December 31, 2024 overlapping covered stays. Revenue Cycle · due Oct 25, 2026
  2. Validate SNF Part A coverage and applicable swing-bed exclusions against sample claims. Coding · due Nov 15, 2026
  3. Establish recoupment reconciliation and escalation procedures for utility adjustments. Finance · due Dec 15, 2026
P2 NEW Directly applicable Final compliance Feb 1, 2027

DMEPOS Round 2028 registration and bid dates are announced

What changed

CMS’s October 7 announcement moves the Round 2028 DMEPOS bid opening into January 2027 to give suppliers more preparation time. Registration opens December 1, 2026 and closes February 1, 2027; bidding opens January 5 and closes March 10. The timeline separately lists February 8 as the Covered Document Review Date. These milestones serve different functions, so completing registration alone does not complete a bid or substitute for reviewing the required financial-document instructions.

The accompanying resources include the Request for Bids instructions, fact sheets and lead-item pricing tools. The timeline marks later bidder-review and supplier-announcement periods as target dates. Contracts and single payment amounts take effect January 1, 2028. A six-month written-order transition applies to contract suppliers serving beneficiaries previously using noncontract suppliers, rather than a general grace period for late bids. Supplier networks should use the official instructions to coordinate bid preparation and continuity planning.

Why it matters
The covered-document review date is February 8, 2027; contracts begin January 1, 2028. The published timeline labels dates as targets. Supplier networks should avoid assuming an opening later in 2026.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Finance, Managed Care, Clinical Operations

What to do nextIdentify affected suppliers and product categories, review official bid instructions and plan financial-document preparation. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Map affected supplier locations and product categories to the Round 2028 materials. Provider Enrollment · due Oct 25, 2026
  2. Prepare financial documents, bond responsibilities and bid governance using official instructions. Finance · due Nov 15, 2026
  3. Track registration and bid milestones, with a separate plan for beneficiary continuity. Managed Care · due Dec 1, 2026
P2 NEW Directly applicable Final

Medi-Cal RSV vaccine billing expands age eligibility and modifier rules

What changed

For service dates from June 12, 2025, the notice makes the RSV vaccine code 90683 available from age fifty. Modifier SK is required for members aged fifty through seventy-four and is not required for members seventy-five and older. A single minimum-age edit therefore does not capture the full billing change: the age at service determines the modifier treatment as well as whether the updated minimum is met.

DHCS plans an Erroneous Payment Correction for appropriately submitted claims from the effective date that were denied because the system had not implemented the policy. Providers may instead correct and resubmit earlier denials using existing claim-inquiry and timeliness instructions. Updated manual sections are forthcoming. Those alternatives support reconciliation of actual eligible denials; they do not prove every denied vaccine claim will pay automatically or that the system correction has already completed.

Why it matters
DHCS will implement an erroneous-payment correction for appropriately submitted claims denied because system changes were missing. Providers may also correct and resubmit under existing timeliness instructions.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, IT

What to do nextUpdate age and modifier edits, identify eligible denied claims and reconcile reprocessing against any resubmissions. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Set age-specific SK edits and test examples at ages 50, 74 and 75. Coding · due Oct 18, 2026
  2. Inventory denials from June 12, 2025 affected by the system lag. Revenue Cycle · due Oct 25, 2026
  3. Reconcile EPC payments with corrected submissions to prevent duplicate recovery. Revenue Cycle · due Nov 8, 2026
P2 NEW Directly applicable Final

Every Woman Counts adds retroactive procedure and diagnosis benefits

What changed

The procedure table makes codes 00940, 10009, 10010, 38505, 88361, 99156, and 99157 reimbursable from October 26, 2024. Code 87626 begins January 1, 2025, while 10035, 10036, 57460, 57461, 57520, 57522, and A9585 begin January 1, 2026. The notice applies these EWC benefits to primary-care and referral providers. Each code group retains its own service-date boundary rather than sharing the October 9 publication date.

Breast-density diagnoses R92.30 through R92.34 are allowable from October 1, 2023. From October 1, 2025, R10.2 is removed and R10.20 through R10.24 are added for the specified cervical screening/diagnosis use. The EPC sentence says affected claims "up to October 26, 2024" will be reprocessed, while also permitting corrected resubmission under existing instructions. That wording does not establish a clear universal start-to-end correction interval covering every listed benefit. Claim-specific uncertainty should be resolved against the actual notice and DHCS instructions.

Why it matters
Breast-density diagnoses date to October 1, 2023; pelvic-pain diagnosis changes date to October 1, 2025. The notice's EPC language refers to affected claims up to October 26, 2024; do not expand that wording into a guaranteed correction period.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations

What to do nextUse the notice's exact code/date tables, review denied claims, and clarify EPC scope where a specific claim's period is uncertain. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Map each added procedure and diagnosis to its specific effective date. Coding · due Oct 18, 2026
  2. Identify eligible denied EWC claims and apply existing correction instructions. Revenue Cycle · due Oct 25, 2026
  3. Reconcile EPC results and clarify ambiguous correction coverage with program support. Revenue Cycle · due Nov 8, 2026
P2 NEW Directly applicable Final implementation Nov 1, 2026

Medi-Cal obstetric E/M transition retains CPSP and doula exceptions

What changed

The notice describes an AMA obstetric coding framework beginning January 1, 2027 and anticipates related CMS changes without claiming those are already issued. Medi-Cal encourages prenatal and postpartum E/M claims with modifier TH from November 1, selected according to documented time and complexity. The recommendation to move toward E/M is distinct from the requirement to include TH when using that pathway, and it is not a blanket immediate prohibition on every existing local code.

Prenatal claims require a gestational-age code in Z3A.00 through Z3A.49; postpartum claims need an applicable code within O86–O92, Z39.0–Z39.2, or F53.0–F53.1. Actual billable subcodes must be used where a listed entry is only a category header, and the notice states the member must be female. CPSP providers and doulas must continue Z1032, Z1034, and Z1038 until further notice. Updated manual sections will follow. These explicit program exceptions and diagnosis conditions need to remain in place when other obstetric workflows transition.

Why it matters
Select E/M by documented time and complexity. Prenatal and postpartum diagnosis rules apply; CPSP providers and doulas must continue local Z codes until further notice. Encouragement is not a blanket immediate ban on every existing code.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Coding
Affected functions
Coding, Clinical Operations, Revenue Cycle, IT

What to do nextMap affected obstetric workflows, preserve program exceptions and train clinicians on documentation and valid diagnosis subcodes. Playbook dates are recommended internal targets, except any explicitly identified agency date.

  1. Separate ordinary obstetric, CPSP and doula workflows before changing edits. Coding · due Oct 18, 2026
  2. Test TH, valid prenatal/postpartum diagnosis subcodes and E/M documentation. IT · due Oct 25, 2026
  3. Train affected clinicians and monitor November claims while retaining stated exceptions. Clinical Operations · due Nov 1, 2026
P2 NEW Operationally relevant Final effective Apr 1, 2027

Hospice claim edits gain transfer and ownership-change bypasses in April 2027

What changed

CMS’s October 8 transmittal 13997, CR 14622, changes hospice edits U5565 and U5566, effective April 1, 2027 and implemented April 5. Those edits return specified hospice claims when the admission date does not match the corresponding election-period start and reject adjustment claims. The instruction adds bypass conditions for hospice-to-hospice transfers and changes of ownership, recognizing circumstances in which the receiving hospice can use its own admission date or the effective date on the ownership-change notice.

CMS had instructed the Common Working File to temporarily turn these edits off on June 18, 2026 while the bypasses were prepared. The new instruction restores them with the additional conditions and requires contractor integration testing. It identifies bill types 813, 814, 823 and 824 in describing the affected processing and explicitly states there is no new policy or legislation. Billing teams should test ordinary admissions and the two exception scenarios separately, using actual election and transaction dates rather than assuming every mismatch is invalid or that every transferred claim escapes all other edits.

Why it matters
The edits compare claim admission dates with election-period starts. CMS temporarily disabled them June 18, 2026 pending these bypasses. Reimplementation must preserve the receiving hospice's valid admission date and ownership-notice date; this CR states no new policy.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Clinical Operations, IT

What to do nextTest normal, transfer and ownership-change scenarios with the billing vendor and confirm the MAC implementation before applying blanket admission-date rejection logic. Playbook dates are recommended internal targets, not additional agency deadlines.

  1. Map the affected claims and operative dates with the accountable owner. Revenue Cycle · due Oct 18, 2026
  2. Test normal, transfer and ownership-change scenarios with the billing vendor and confirm the MAC implementation before applying blanket admission-date rejection logic. IT · due Oct 25, 2026
  3. Reconcile representative claims and retain implementation evidence before the operative release. Revenue Cycle · due Nov 1, 2026
P2 NEW Operationally relevant Final effective Apr 1, 2027

Home health edit repair addresses purged Notices of Admission

What changed

CMS’s October 8 transmittal 13996 addresses reason code 19963 on home-health type-of-bill 032x claims. The problem occurs when both the From and Through dates fall within twenty-four months of admission but the claim arrives after that period and its Notice of Admission record has been purged from the Fiscal Intermediary Shared System. CR 14605 is effective April 1, 2027, with April 5 implementation, so its correction should be distinguished from current handling of a returned claim.

Under the specified conditions, the contractor must accept the claim and send the admission date to the Home Health Pricer in its receipt-date field. The instruction preserves the requirements of CR 13684 and states that it contains no new policy. This is a targeted system repair, not a general extension of filing time or permission to omit a required NOA. Providers identifying affected returns should retain the actual admission and notice evidence and verify all three date conditions, rather than treating every missing-NOA return as the same processing defect.

Why it matters
FISS can purge the corresponding NOA before late claims arrive. The specified repair accepts these claims and passes the admission date to the pricer in the receipt-date field. It states no new policy and does not waive all filing limits or other claim requirements.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Clinical Operations

What to do nextIdentify qualifying 032x returns, retain NOA evidence, and test the specified date conditions with the MAC and billing vendor. Playbook dates are recommended internal targets, not additional agency deadlines.

  1. Map the affected claims and operative dates with the accountable owner. Revenue Cycle · due Oct 18, 2026
  2. Identify qualifying 032x returns, retain NOA evidence, and test the specified date conditions with the MAC and billing vendor. IT · due Oct 25, 2026
  3. Reconcile representative claims and retain implementation evidence before the operative release. Revenue Cycle · due Nov 1, 2026
P2 NEW Operationally relevant Final effective Oct 1, 2026

October ASC update changes codes, skin substitutes and retroactive pricing

What changed

CMS transmittal 13983, CR 14634, describes the October 2026 ambulatory surgical center payment update, generally effective October 1 with October 5 implementation. The October 8 document includes ten new category III codes, replacement of C8010 by 1091T, twelve new drug pass-through codes and eight new skin-substitute product codes. Five skin-substitute descriptors change retroactively to April 1. Stimuplex needles qualify for the specified additional non-opioid payment under C9812 beginning April 30. These different dates require item-specific validation rather than one uniform file cutover.

The instruction also requires contractors to search and reprocess appropriate A9521 claims for May 14–September 30 service dates and J9161 claims for July 1–September 30, within thirty days of implementation. Other restated drug prices may be addressed through provider resubmission, so that general option should not replace the two mandatory contractor searches. CMS expressly cautions that an assigned code and rate indicate how a covered service may be paid, not whether it is covered. Claim review therefore needs the applicable descriptor, payment indicator, service date, coverage rules and supporting clinical documentation.

Why it matters
The update replaces C8010 with 1091T; revises skin-substitute add-on descriptors retroactive to April 1; adds codes and retires drug codes September 30. MACs reprocess A9521 from May 14 and J9161 from July 1 through September 30 within 30 days of implementation. Stimuplex joins C9812 effective April 30. A code or rate does not establish coverage.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations, IT

What to do nextLoad the applicable code, descriptor and payment-indicator tables; test date-specific claim edits and reconcile affected reprocessing against actual coverage and documentation. Playbook dates are recommended internal targets, not additional agency deadlines.

  1. Map the affected claims and operative dates with the accountable owner. Coding · due Oct 18, 2026
  2. Load the applicable code, descriptor and payment-indicator tables; test date-specific claim edits and reconcile affected reprocessing against actual coverage and documentation. IT · due Oct 25, 2026
  3. Reconcile representative claims and retain implementation evidence before the operative release. Revenue Cycle · due Nov 1, 2026
P2 NEW Operationally relevant Final effective Jan 1, 2027

Home health consolidated billing removes two supply codes in January

What changed

CMS’s October 8 transmittal 13988, CR 14639, removes A4453 and A4459 from the home-health non-routine-supply consolidated-billing code list for line-item service dates on or after January 1, 2027. The codes describe specified transanal-irrigation catheter and manual-pump enema-system supplies. Implementation is January 4. The annual instruction makes no addition to the therapy code list, so the two supply-code removals should not be generalized to an expansion of separately billable therapy.

Consolidated billing ordinarily directs payment for listed services during a home-health episode to the primary home-health agency, with the stated exceptions for physician-performed therapies and specified incidental or institutional supplies. CMS explains that recurring code-list changes enforce the existing benefit rather than redefine the services included in it. Billing teams should therefore change the two relevant edits by service date while preserving episode, coverage and documentation checks. A code’s removal from this list is not, by itself, a determination that every separately submitted claim for that product is payable.

Why it matters
No therapy-code additions are announced. The update changes coding used to enforce existing consolidated billing, rather than redefining the entire covered service set. Removal does not establish automatic payment or coverage.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, IT

What to do nextUpdate the January exclusion table, test these two supply codes and retain other home health episode and coverage checks. Playbook dates are recommended internal targets, not additional agency deadlines.

  1. Map the affected claims and operative dates with the accountable owner. Coding · due Oct 18, 2026
  2. Update the January exclusion table, test these two supply codes and retain other home health episode and coverage checks. IT · due Oct 25, 2026
  3. Reconcile representative claims and retain implementation evidence before the operative release. Revenue Cycle · due Nov 1, 2026
P2 NEW Operationally relevant Announced implementation Dec 1, 2026

HETS users: verify enrollment email by December 1 to avoid rejected eligibility requests

What changed

CMS’s October 8 MLN Connects newsletter tells users of the HIPAA Eligibility Transaction System, or HETS, to ensure the email on their HETS EDI enrollment is correct by December 1, 2026. HETS 270/271 transactions check Medicare eligibility through billing software, electronic health records, practice-management systems or clearinghouses. A notification from the clearinghouse about delivery failure, or a missing monthly transaction-count report after enrollment, is a reason to check the contact address. CMS directs providers to correct the address through their Medicare Administrative Contractor, or MAC; the billing company, EHR vendor or clearinghouse cannot make that enrollment-email change for them.

The suspension condition is specific: if the HETS email fails to deliver on all three consecutive monthly dates, October 1, November 1 and December 1, 2026, CMS says HETS will suspend that enrollment and reject eligibility requests for the affected NPI. HETS returns an error until the address is corrected through the MAC. The notice does not describe a dry-run test, automatic suspension of every user in December, or loss of the patient’s Medicare eligibility. It identifies an administrative failure that can interrupt the eligibility-checking workflow even when the transaction software itself is working.

Why it matters
An eligibility workflow can stop even when the transaction software works if the provider enrollment contact cannot receive reports.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Provider Enrollment

What to do nextConfirm report receipt and correct the email through the MAC; test eligibility transactions. Playbook dates are recommended internal targets.

  1. Inventory HETS users and confirm October report delivery. Revenue Cycle · due Oct 18, 2026
  2. Correct enrollment email through the MAC and verify November delivery. Provider Enrollment · due Nov 8, 2026
  3. Confirm December delivery and successful eligibility transactions. IT · due Dec 1, 2026
P2 NEW Directly applicable Effective

Noridian repairs G0260 imaging-code payment edit retroactively

What changed

Noridian’s October 6 update reports a systems correction to reason code 5088L for G0260 claims. For dates of service on or after January 25, 2024, the edit no longer requires the procedure to be billed together with imaging code 77002 or 77012 to allow payment. This is a specific correction to an existing payment edit with a historical service-date reach, rather than a newly announced prospective benefit.

The notice expressly retains type of bill 13X and the listed diagnosis criteria, M43.28, M46.1, M47.818 or M53.3. Removing the imaging-code pairing therefore does not remove all conditions for payment or make every previously denied claim payable. Revenue-cycle teams can identify denials tied to 5088L, verify the remaining criteria and ask Noridian which adjustment route applies. The notice itself does not specify an automatic reprocessing schedule.

Why it matters
The remaining 13X bill-type and listed diagnosis conditions continue. This edit repair does not remove all sacroiliac injection coverage or documentation requirements.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations

What to do nextIdentify affected denials and ask the MAC which correction or adjustment process applies; retain the remaining criteria. Playbook dates are recommended internal targets.

  1. Identify G0260 denials linked to 5088L for qualifying service dates. Revenue Cycle · due Oct 18, 2026
  2. Verify remaining bill-type and diagnosis requirements and obtain the MAC correction route. Coding · due Oct 25, 2026
  3. Test corrected claims and reconcile actual payment outcomes. Revenue Cycle · due Nov 1, 2026
P2 NEW Directly applicable Final compliance Dec 1, 2026

Recuperative care changes preserve phased housing sunset and member transitions

What changed

The revised definition takes effect January 1, 2027; the current definition continues through December. Medi-Cal stops covering room and board, although facilities must still provide beds and meals. Required care includes onsite coordination, daily wellness checks, safe medication storage, and qualified supervision. All supervisors need staff or team-management experience and regular onsite availability; LCSW and MSW pathways also require specified health-care experience. The six-month rolling service limit continues. NIMRC certification is encouraged, and DHCS does not impose a new January facility-licensure requirement.

New STPHH authorizations stop after December 1, except that the cutoff is December 31 for members transitioning from managed care to FFS under the UIS transition. No authorization may extend beyond December 31. Plans must issue standardized member notices by December 1 and support connections to appropriate services, rather than assume every member qualifies for recuperative care. Shortening a requested authorization can trigger appeal rights. Earlier room-and-board months remain relevant to the rolling global-cap runout even when later recuperative-care months no longer count.

Why it matters
MCPs offering STPHH must send standardized member notices by December 1, support transitions, update provider agreements and January materials, and report monthly through December; the last report is due January 10. Reduced requested authorizations can trigger appeal rights. Earlier room-and-board months still count during the rolling-cap runout.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Case Management
Affected functions
Case Management, Managed Care, Clinical Operations, Utilization Management, Revenue Cycle, Compliance

What to do nextCase Management and Managed Care should identify every affected member and prepare notice, referral and contract transitions. For January recuperative care, check supervision, daily wellness checks, safe medication storage and six-month rolling limits. NIMRC certification remains encouraged, rather than newly mandatory.

  1. Inventory active STPHH members, UIS delivery-system transitions and requested authorization lengths. Internal target. Case Management · due Oct 18, 2026
  2. Send required standardized member notices and enforce the general cutoff for new STPHH authorizations; preserve the UIS exception. Managed Care · due Dec 1, 2026
  3. Implement revised recuperative-care staffing and service controls and complete benefit and provider-material updates. Clinical Operations · due Jan 1, 2027
  4. Submit the final December STPHH transition-monitoring report; follow DHCS instructions for earlier monthly reports. Managed Care · due Jan 10, 2027
P2 NEW Directly applicable Draft comment Oct 16, 2026

Recuperative-care pricing feedback closes October 16

What changed

The standalone October pricing resource models a $216.86 per-diem midpoint for T2033 U6 under the service definition effective January 1, 2027. It excludes room and board while accounting for enhanced coordination and supervision. DHCS requests written feedback by October 16 at [email protected], using the subject “Feedback on the Recuperative Care Pricing Resource.” This comment opportunity concerns pricing guidance; it does not make the model a final required reimbursement rate.

The model assumes a ten-member caseload, one supervisor for 4.2 team members, and 0.4 clinical-consultant FTE per ten members. Those assumptions describe the benchmark rather than a universal contractual staffing ratio. Plans and providers may negotiate above or below it or use alternative payment methods. DHCS directs attention to acuity, realistic caseloads, program size, staffing, and geographic cost differences, explaining why one uniform rate may not fit every program. A local comparison should therefore test the modeled inputs before treating the midpoint as adequate for a particular facility.

Why it matters
The benchmark excludes room and board and supports negotiations. It is neither a required rate nor a floor or ceiling; acuity, staffing, caseload and geography affect actual costs.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Finance
Affected functions
Finance, Managed Care, Clinical Operations, Compliance

What to do nextFinance and Managed Care should compare the model with local service costs and prepare any desired feedback using the specified subject line. Submission is optional; do not apply the draft midpoint as a mandatory payment rate.

  1. Compare January staffing and service costs with the draft model and prepare optional feedback. Internal target. Finance · due Oct 14, 2026
  2. If commenting, submit feedback with the requested subject line by the agency deadline. Managed Care · due Oct 16, 2026
P2 NEW Directly applicable Announced

Four county behavioral-health plans remain subject to temporary network withholds

What changed

The October 5 update reports September 28 final notices to Merced, Santa Clara, Shasta, and San Francisco behavioral health plans. DHCS identifies failures to meet timely-access and network-adequacy standards for two consecutive certification years under BHIN 25-013. The department initially identified ten plans with uncorrected deficiencies reflected in its 2025 specialty mental-health and DMC-ODS compliance findings. The newsletter therefore reports a later, narrower enforcement group rather than imposing a new obligation on every county.

After meet-and-confer sessions and additional evidence under Welfare and Institutions Code section 14197.7, DHCS determined that Fresno, Napa, San Mateo, Tehama, Tulare, and Ventura had corrected the relevant deficiencies and would avoid these withholds. The four remaining plans must demonstrate compliance before withheld funds are released. The update provides no individual withholding amounts, collection status, or later release determination. Financial reconciliation should consequently use each actual notice and corrective record, while network teams track the access deficiencies that condition release; the announcement is not evidence of a civil settlement or permanent forfeiture.

Why it matters
DHCS will not proceed against Fresno, Napa, San Mateo, Tehama, Tulare or Ventura after corrective evidence. The remaining withholds are released upon demonstrated compliance. This is a historical action update, not an October 5 civil settlement or an announced permanent penalty.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Managed Care
Affected functions
Managed Care, Finance, Quality, Clinical Operations, Compliance

What to do nextManaged Care and Finance should reconcile exposure to the four affected plans, verify actual notices and monitor corrective milestones. Do not infer withholding amounts, collection, or later release from the newsletter.

  1. Reconcile affected county-plan contracts and actual notice terms. Internal target. Managed Care · due Oct 18, 2026
  2. Review local access and network corrective evidence and escalation ownership. Internal target. Quality · due Oct 25, 2026
P2 NEW Directly applicable Final implementation Jan 1, 2027

Behavioral-health data sharing needs separate MCP and county implementation phases

What changed

APL 26-004 required managed-care plans to implement clarified exchange procedures by April 1, 2026. BHIN 26-013 gives behavioral-health plans and DMC counties until January 1, 2027 for the specified procedural updates; both systems must adopt ASCMI by January 1. Core care-coordination duties already apply. The October 14 learning collaborative is voluntary technical assistance, with one registration per county/plan dyad, rather than a substitute for implementation. January also marks focused monitoring and potential corrective or monetary enforcement.

The directives require bidirectional care-coordination information and ADT notifications without intentional delay, supported by at least monthly up-to-date rosters. Required reporting exchanges need not occur in real time. Part 2 roster information requires valid consent, and CalAIM permissions do not override federal privacy rules. ASCMI standardizes required consent without making every disclosure permissible. A signed revocation received by the provider protects information not yet shared, including earlier-collected data; it does not undo disclosures already made in reliance on consent. Plans must support consent storage and communicate obligations downstream.

Why it matters
Monthly rosters and bidirectional ADT notifications support coordination, but required reporting exchange need not be real time. Part 2 roster disclosures require valid consent. CalAIM permissions do not override federal privacy restrictions, and revocation protects information not yet disclosed.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
IT
Affected functions
IT, Compliance, Managed Care, Clinical Operations, HIM/CDI

What to do nextIT, Compliance and Managed Care should test exchange with each county partner, reconcile the earlier MCP phase, implement consent ingestion and revocation controls, and communicate requirements to network providers. Participation in the voluntary session does not replace implementation.

  1. Test partner rosters and ADT exchange and identify any overdue MCP procedural changes. Internal target. IT · due Oct 25, 2026
  2. Complete ASCMI adoption, valid Part 2 consent and prospective revocation controls; counties complete applicable procedural updates. Compliance · due Jan 1, 2027
P2 NEW Directly applicable Announced implementation Dec 1, 2026

Qualified non-citizen notices distinguish funding from January care delivery

What changed

MEDIL 26-21 was issued July 31; its enclosed member notice is dated October 1. It addresses listed qualified non-citizens losing federal full-scope eligibility from October 1, including refugees, asylees, specified parolees, conditional entrants, people with withheld deportation, and battered immigrants. The October 5 newsletter describes an automatic transition to state-funded full-scope coverage through July 1, 2027; the July MEDIL gives no end date. Loss of federal funding does not end all care; this population differs from UIS.

The notice separately explains that affected members move from managed care to fee-for-service on January 1, 2027, use their BIC, and need providers accepting FFS. Some plan-only services will end, so continued full-scope eligibility does not mean an unchanged delivery system. Members whose immigration status changed or whose county information may be outdated must update it by December 1. Other renewal or information requests retain their own stated deadlines. Checking provider participation, replacing a missing BIC, and responding to actual county requests support continuity without inventing a universal December renewal requirement.

Why it matters
Automatic funding transition does not mean the later delivery system is unchanged. The letter asks members with changed or inaccurate immigration information to update county records by December 1 and check whether current providers accept FFS. This population must not be conflated with UIS.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Patient Access
Affected functions
Patient Access, Managed Care, Case Management, Provider Enrollment, Compliance

What to do nextPatient Access should use the current county/member notice, support needed record updates and confirm FFS participation and continuity. Do not tell members their full-scope coverage stopped October 1 or require a new application solely for automatic state-funding transition.

  1. Compare affected QNC notices with UIS workflows and confirm continuity counseling. Internal target. Patient Access · due Oct 18, 2026
  2. Help members update changed or inaccurate immigration information by the date specified in their notice. Patient Access · due Dec 1, 2026
  3. Confirm FFS participation and continuity routes for affected January transitions. Provider Enrollment · due Jan 1, 2027
P3 CARRYOVER Directly applicable Final implementation Oct 5, 2026

October Medicare and Medi-Cal claims updates: reconcile completed implementation

What changed

The current EDI instruction is September 28 R13977, replacing R13967 to update the 276/277 attachment while retaining October 1 effectiveness and October 5 implementation. Other October releases use distinct triggers. MPFS R13929 amends 2026 payment files, with January 1 general effectiveness and individual-record dates. CLFS/CLIA uses CR 14569 and MM14569, effective October 1 and implemented October 5. SNF MM14561 removes specified therapy codes from Part B File 1 while retaining them in File 4, with October 5 placement dates in Table 8. Home-health R13793 requires grouper 07.2.26 for claim From dates on or after October 1 for bill type 032x except 32A and 320. These contractor milestones require release verification rather than an assumption that every local system installed the files.

Adjustment instructions also differ. SNF, MPFS, and CLFS sources describe adjusting affected claims brought to the MAC's attention without a general file search, whereas OPPS R13978 specifically requires Q5161 claims received July 1 through July 20 to be adjusted within 30 days of implementation. OPPS coding/payment changes do not themselves establish Medicare coverage. DMEPOS MM14619 separates October code and fee changes from January 2028 CGM/pump bundling and its patient-owned-equipment transition. Medi-Cal NCCI edits use claims received from October 1; Q4 HCPCS changes generally use service dates from October 1 unless specified otherwise. Reconciliation must therefore preserve each source's claim population, retroactive dates, and exception rather than applying one October deadline or reopening rule to every claim.

Why it matters
A contractor implementation date is not a provider filing deadline or proof that a vendor applied the release. Medi-Cal NCCI edits turn on claims received from October 1; Q4 HCPCS changes generally turn on dates of service from October 1. Coding and payment changes do not establish coverage, and retroactive corrections retain their separate dates.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Coding, Finance
First seen
Aug 30, 2026
Last materially changed
Oct 4, 2026
Why it is still here
The October 5 implementation milestone is within the payer resurfacing window. Confirm actual local deployment and claims behavior; official instructions were rechecked. The inaccessible historical outage article remains explicitly unverified.

What to do nextRevenue Cycle and IT should obtain actual release evidence for current R13977 EDI, CR14588 MPFS, CR14569 CLFS/CLIA, CR14561 SNF, and home-health grouper 07.2.26 updates, distinguishing each effective trigger from October 5 contractor implementation. Reconcile applicable claims and use MM14561 to verify therapy-code placement. Bring affected SNF, MPFS, and CLFS claims to the MAC as instructed; preserve the separate mandatory Q5161 adjustment for claims received July 1 through July 20. Apply each Medi-Cal receipt-date or service-date rule correctly. The previously reported Noridian October 2–4 downtime window has elapsed; current restoration or ongoing outage remains unverified. January 2027 releases and January 2028 DMEPOS policy remain separate.

OfficialRescinded EDI transmittal R13934OTN: replacement is R13967OTN · Centers for Medicare & Medicaid Services · Source published Aug 27, 2026 · Verified Oct 11, 2026 ↗ OfficialTransmittal R13929CP, change request 14588, quarterly update to the Medicare Physician Fee Schedule Database, October 2026 · Centers for Medicare & Medicaid Services · Source published Aug 27, 2026 · Verified Oct 11, 2026 ↗ OfficialMLN Connects newsletter, August 27, 2026 · Centers for Medicare & Medicaid Services · Source published Aug 27, 2026 · Verified Oct 11, 2026 ↗ OfficialMLN Connects, September 3, 2026 · CMS · Source published Sep 3, 2026 · Verified Oct 11, 2026 ↗ OfficialMM14561, SNF consolidated billing October update · CMS · Source published Sep 2, 2026 · Verified Oct 11, 2026 ↗ OfficialNCCI quarterly update effective October 1 · DHCS · Source published Aug 31, 2026 · Verified Oct 11, 2026 ↗ OfficialPortal, IVR and customer-service limited availability October 2-4 · Noridian, Jurisdiction E · Source published Sep 1, 2026 · Verified Sep 6, 2026 ↗ OfficialCMS Transmittal R13978CP · Centers for Medicare & Medicaid Services · Source published Sep 29, 2026 · Verified Oct 11, 2026 ↗ OfficialCMS Transmittal R13979CP · Centers for Medicare & Medicaid Services · Source published Sep 29, 2026 · Verified Oct 11, 2026 ↗ OfficialCMS Transmittal R13956CP · Centers for Medicare & Medicaid Services · Source published Sep 29, 2026 · Verified Oct 11, 2026 ↗ Official2026 HCPCS Quarter 4 Update · DHCS · Source published Sep 29, 2026 · Verified Oct 11, 2026 ↗ OfficialMM14619, DMEPOS Fee Schedule October 2026 Quarterly Update · CMS · Source published Sep 30, 2026 · Verified Oct 11, 2026 ↗ OfficialMM14589, Hospital OPPS October 2026 Update · CMS · Source published Oct 1, 2026 · Verified Oct 11, 2026 ↗ OfficialTransmittal 13791, CR 14492, CARC/RARC and remittance software update · CMS · Source published May 27, 2026 · Verified Oct 11, 2026 ↗ OfficialReplacement EDI transmittal R13967OTN, CR 14429 · CMS · Source published Sep 18, 2026 · Verified Oct 11, 2026 ↗ OfficialCurrent EDI replacement transmittal R13977OTN, CR14429 · CMS · Source published Sep 28, 2026 · Verified Oct 11, 2026 ↗ OfficialCMS R13929CP, CR14588, actual official PDF instruction · CMS · Source published Aug 27, 2026 · Verified Oct 14, 2026 ↗ OfficialCMS R13793CP, CR14509, home-health grouper instruction · CMS · Source published Jul 8, 2026 · Verified Oct 14, 2026 ↗ OfficialCMS MM14569, October CLFS and CLIA update · CMS · Source published Aug 25, 2026 · Verified Oct 14, 2026 ↗
P3 CARRYOVER Operationally relevant Final effective Jan 1, 2027

CMS refreshes hospice telecommunications recertification reporting guidance

What changed

Revised MLN Matters article MM14495 explains how hospices must report face-to-face recertification encounters conducted by a hospice physician or nurse practitioner using telecommunications technology. The reporting instruction takes effect January 1, 2027, with contractor implementation January 4. CMS specifies HCPCS G0679 for the encounter and describes it as an administrative expense. The service must appear in line-item detail, with each service on a separately dated line under the appropriate revenue code. The instruction concerns the coding of the recertification encounter; it does not itself establish a separate authorization to furnish telehealth beyond the applicable statutory rules.

CMS says the Medicare Administrative Contractor will return a G0679 claim if its type of bill is other than 81X or 82X, or if its revenue code is other than 0657. That makes the relationship between the encounter documentation, bill type and claim-line coding important for implementation. The article’s background links the reporting requirement to specified virtual-platform contractual or payment arrangements and incident-to professional services. Its September 2 revision changed only the change-request release date, transmittal numbers and links, not the substantive policy. The reporting start date therefore needs preparation, but the revised article should not be described as a new September entitlement or a new expansion of telehealth services.

Why it matters
This is newly tracked guidance in this briefing, not a new September policy. Incorrect claim combinations can cause returns.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations, IT
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Revenue Cycle should validate hospice claim templates and coding with the current instruction, distinguishing the January 1 effective date from January 4 implementation.

What to do nextRevenue Cycle should validate hospice claim templates and coding with the current instruction, distinguishing the January 1 effective date from January 4 implementation.

P3 CARRYOVER Operationally relevant Final effective Jan 1, 2027

CMS explains January Medicare Secondary Payer adjustment-code processing

What changed

MLN Matters article MM14553 describes Medicare Secondary Payer claims-processing changes under CR14553 and transmittal R13932OTN. The instruction is effective January 1, 2027, with implementation January 4. It directs Part A Medicare Administrative Contractors and their shared claims systems on which claim adjustment reason codes can process automatically and which require suspension for manual review or denial. These are processing rules for claims in which Medicare is secondary. They do not mean that every adjustment code follows the same automated route or that a returned claim has necessarily reached a final payment determination.

The underlying data comes from the primary payer’s payment information. CMS instructs providers to take the claim adjustment segment values from the primary payer’s 835 remittance and report them unchanged on the institutional 837 submitted to Medicare for secondary payment. Contractors use those adjustment amounts and reason codes to calculate the Medicare payment. If Medicare cannot process a claim, the contractor may return it with a reason on the remittance advice, allowing correction and, in many cases, resubmission to Medicare or the primary payer. The operational work is therefore to preserve the original adjustment data and route returned claims for appropriate correction, rather than inventing replacement adjustment amounts to force processing.

Why it matters
Claim adjustments from the primary payer must flow unchanged from the 835 into the secondary 837. Returned claims may need correction and resubmission.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, IT
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Revenue Cycle and IT should validate primary-payer adjustment mapping and returned-claim workflows with their MAC before January implementation.

What to do nextRevenue Cycle and IT should validate primary-payer adjustment mapping and returned-claim workflows with their MAC before January implementation.

P3 CARRYOVER Potentially applicable Proposed comment Oct 11, 2026

Noridian opens three proposed MolDX policies for comments through October 11

What changed

The August 31 notice lists DL40435 for renal-carcinoma transcriptional biomarkers, DL40427 for NGS in hematologic malignancies, and DL40411 for genome-wide detection of copy-number alterations and structural variants in hematologic neoplasms. Its comment period runs August 27 through October 11.

The listed contracts cover northern/southern California, Nevada, and specified Pacific jurisdictions. Noridian directs commenters to identify the specific policy and consult its submission instructions. The notice itself does not finalize these drafts or establish their detailed clinical criteria.

Why it matters
Affected laboratories and ordering services can review proposed coverage criteria before finalization. Publication for comment does not create a final coverage policy or a current billing change.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California, Hawaii, Nevada
Primary owner
Coding
Affected functions
Coding, Clinical Operations, Revenue Cycle, Compliance
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
The current official comment-period notice was rechecked; the deadline is within 30 days and remains actionable today. No finalization is inferred from the proposal.

What to do nextCoding and laboratory leaders should review the three proposed LCDs, assess their test menus, and decide whether to submit evidence-based comments by October 11. Keep this proposal separate from the finalized October MolDX changes.

P3 CARRYOVER Potentially applicable Final

CMS adjusts September plan payment user fees

What changed

CMS schedules the September 2026 plan payment for September 1 and describes final annual COB and NMEC fee adjustments. To collect the $0.65 annual COB fee per member, the January–August monthly rate of 7.2 cents becomes 7.4 cents for September. The MA-PD NMEC collection rate rises from 0.021 percent to 0.029 percent to reach the $108.9 million annual amount. September includes no PDP NMEC assessment because the $11.4 million maximum was reached in August. These are distinct plan-payment calculations, rather than one percentage applied to every Medicare payment.

The memo places required 2024 medical-loss-ratio remittances in the August 2026 payment under the PPR adjustment code MLR. It separately reiterates the restored 2 percent statutory sequester and corresponding retroactive adjustments. For payment inquiries, CMS points plans to the MAPD Help Desk and explains that organizations with an already submitted trouble ticket need not resubmit it, including where a common parent ticket consolidates issues. Those reconciliation instructions do not establish that a particular organization owes a new amount or that October brought another fee-rate change.

Why it matters
Health systems or networks with plan operations need to reconcile the September 1 payment against the final annual fee adjustments. The memo places 2024 medical-loss-ratio remittances in the August payment, under code MLR.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Managed Care, Compliance
First seen
Sep 6, 2026
Last materially changed
Sep 6, 2026
Why it is still here
Both pages of the official August 31 CMS memo were visually read in Chrome October 11. Retained for reconciliation of the September payment and prior August MLR remittance; no new October payment change is asserted.

What to do nextPlan finance teams should compare September remittances with the revised COB and MA-PD NMEC rates, confirm the PDP exception, and investigate variances through the MAPD Help Desk.

P3 CARRYOVER Operationally relevant Final implementation Jan 1, 2028

California directs DHCS to establish Medi-Cal vision performance measures

What changed

DHCS must establish vision-service measures by January 1, 2028 for children and adults across fee-for-service and managed care, including specialized vision plans. The statute identifies utilization, examination-to-eyeglass delivery time for specified state-fabricated glasses, rendering-provider counts and credentials, diagnoses, examinations, screenings, prescriptions, and dispensing. Reporting should use aggregate numbers and appropriate percentages and an equity framework using available geographic and demographic factors. DHCS need only calculate measures for which existing data sources are available.

By January 1, 2029, DHCS must publish the measure list and calendar-year 2026 results, with later annual reporting. After evaluating the first three reporting years beginning in 2026, it must set initial benchmarks by July 1, 2029 for use in 2030 and update them thereafter. The annual vision complaint/grievance summary likewise relies on existing accessible sources. These provisions do not require a new data-collection mechanism where information is absent or impose an immediate provider submission. Preserving baseline data and monitoring specifications are preparation for the agency's staged program.

Why it matters
Plans and vision networks will need reliable baseline, encounter, access, utilization, complaint, and grievance data that can be stratified as the statute requires.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Quality
Affected functions
Quality, Managed Care, IT, Compliance
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; ongoing implementation or monitoring remains: Preserve 2026 baseline data, assign a vision-measure owner, inventory data gaps, and monitor DHCS specifications before changing reporting.
Long lead justification
The January 2028 measure-development milestone exceeds 180 days, but initial publication uses 2026 baseline data. Preserving existing encounter, access, utilization and complaint data now supports later vision-measure and stratification work without inventing a new provider reporting duty. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextPreserve 2026 baseline data, assign a vision-measure owner, inventory data gaps, and monitor DHCS specifications before changing reporting.

P3 CARRYOVER Operationally relevant Final

CMS releases FY 2025 SNF PEPPER reports

What changed

The September 17 newsletter announces the FY 2025 Program for Evaluating Payment Patterns Electronic Report for skilled nursing facilities. CMS describes using PEPPER to identify billing patterns needing review, possible undercoding or overcoding, and trends such as longer stays. Those uses support focused internal review; a comparative pattern is not by itself a fraud finding, repayment decision, or proof that a particular service was medically unnecessary.

Authorized officials, access managers, and approved staff end users can download their organization's report from the PEPPER Portal. Staff users request the PEPPER business function through CMS's Identity and Access system using the described existing credentials, and an authorized official or access manager must approve the request. CMS links training, a user guide, and access assistance. The access workflow is separate from analyzing report results and does not make the public newsletter a new general filing deadline for every SNF.

Why it matters
SNFs can use the report to identify billing patterns that differ from peers before those patterns become audit or repayment issues.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Coding, Clinical Operations
First seen
Sep 20, 2026
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; remaining operational task: Download the facility report, route it to compliance and revenue cycle, investigate material outliers, and document any corrective action.

What to do nextDownload the facility report, route it to compliance and revenue cycle, investigate material outliers, and document any corrective action.

P3 CARRYOVER Operationally relevant Final implementation Nov 2, 2026

MACs must post quarterly Targeted Probe and Educate denial trends

What changed

The September 30 transmittal seeks consistent TPE website postings across MACs. Its business requirement calls for quarterly results showing the top or most common denial reasons, listing three if applicable, for each prioritized problem. The revised manual describes at least the three most common reasons per problem; contractors should include additional reasons when useful to the supplier community. This is a contractor publication instruction, rather than a new quarterly report that every provider must submit.

The surrounding provider-error-rate guidance treats the nature, dollar value, and history of a problem as relevant to corrective action. It includes denials for failure to respond to additional-documentation requests in error-rate calculations and distinguishes prepayment allowable-charge and postpayment paid-error formulas. Those provisions explain why a published topic can guide documentation checks without proving a particular provider's error rate or sanction. An organization still needs its own applicable claims, records, and contractor communications before drawing that conclusion from a general trend posting.

Why it matters
Published denial patterns can guide prospective claims monitoring and education before an organization receives a TPE notice.
Response type
Monitor
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Compliance
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Assign a quarterly review of California-relevant MAC TPE postings and use applicable denial reasons to select documentation samples.

What to do nextAssign a quarterly review of California-relevant MAC TPE postings and use applicable denial reasons to select documentation samples.

  1. Assign a quarterly review of California-relevant MAC TPE postings and use applicable denial reasons to select documentation samples. Compliance · due Nov 2, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Operationally relevant Announced

Medicare premium rebate FAQ supports patient assistance

What changed

The October 3 FAQ says eligible beneficiaries will receive one $90 rebate in October. It anticipates most direct deposits on or around October 8 and some Treasury paper checks later in the month, using the address registered with Medicare. It describes the payment as an offset to an October premium rather than reimbursement for a particular clinician's bill. The expected dates are agency payment guidance, not proof that every eligible person was paid by October 8.

The eligibility discussion concerns Original Medicare Part B beneficiaries living in the United States, references Medicaid premium assistance and income-related premium adjustments, and expressly excludes Medicare Advantage enrollment. Its wording should not be simplified into an eligibility promise for a particular patient. CMS directs eligibility questions to 1-800-MEDICARE and payment-status questions to Social Security at 1-800-772-1213 beginning October 15. Staff can explain those routes while keeping the rebate separate from provider account balances and referring uncertain eligibility determinations to Medicare.

Why it matters
Patient teams may receive questions about eligibility and payment timing that cannot be answered by changing a medical bill.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Patient Access
Affected functions
Patient Access, Revenue Cycle
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Use the CMS FAQ for eligibility questions and agency contacts. Do not promise eligibility or offset patient balances based solely on the rebate announcement.

What to do nextUse the CMS FAQ for eligibility questions and agency contacts. Do not promise eligibility or offset patient balances based solely on the rebate announcement.

  1. Use the CMS FAQ for eligibility questions and agency contacts. Do not promise eligibility or offset patient balances based solely on the rebate announcement. Patient Access · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Operationally relevant Proposed comment Nov 2, 2026

CMS seeks comments on Part D event records and provider cost-report collections

What changed

The October 1 notice sends a revised Prescription Drug Event collection, CMS-10174, to OMB review with comments due November 2. CMS explains that claims-level records support Part D payment calculations, reconciliation, validation, quality monitoring, and program integrity. The identified users include plans, PBMs, third-party administrators, and pharmacies. A collection-review notice describes the reporting instrument and its stated uses; it does not itself announce a new covered drug benefit or demonstrate that OMB has completed approval of the revision.

The September 29 notice separately requests November 30 comments on reinstating OPO designation/agreement forms CMS-576 and CMS-576A without change and extending the home-health cost report CMS-1728-20. The latter supports reimbursement, rate-setting, and financial analysis; the OPO forms support designation and the Medicare agreement. These are sixty-day proposed-collection reviews, distinct from the PDE notice's thirty-day OMB stage. Preparers should identify the applicable collection and comment route rather than treating November 2 as a common deadline for every form named in the combined article.

Why it matters
Plans, PBMs and affected cost-report preparers can evaluate reporting burden and proposed collection details.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Finance
Affected functions
Finance, Managed Care, Compliance
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Assign relevant preparers to assess the collections and submit comments only through the normal organizational approval process.

What to do nextAssign relevant preparers to assess the collections and submit comments only through the normal organizational approval process.

  1. Assign relevant preparers to assess the collections and submit comments only through the normal organizational approval process. Finance · due Nov 2, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CHANGED Operationally relevant Draft comment Oct 14, 2026

DHCS seeks comment on qualified-individual waiver pathways

What changed

CDSS would review requests, consulting DHCS for behavioral-health plans. The three routes allow BHP development and submission, provider development with BHP submission, or provider development and direct submission after BHP signature. All retain independence safeguards. Ordinary BHP employment alone needs no waiver unless the specified placing-agency or placement-setting connection applies. Training, conflict controls, and ongoing monitoring remain required.

Approval would last one year, with renewal requested at least sixty days before expiration. Waivers cannot be shared across counties; loss of qualifications requires immediate removal and CDSS notice. SMHS reimbursement still requires a qualified Medi-Cal provider and compliant documentation. The official index posts October 14 feedback; these draft conditions are not yet final instructions.

Why it matters
Residential treatment and contracted behavioral health assessment programs need to assess whether the proposed pathways preserve independent placement decisions.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Case Management, Legal

What to do nextReview the draft with child welfare and behavioral health partners; evaluate conflicts and decide whether organizational comments are warranted.

  1. Review the draft with child welfare and behavioral health partners; evaluate conflicts and decide whether organizational comments are warranted. Clinical Operations · due Oct 14, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Operationally relevant Final implementation Oct 5, 2026

RHC and FQHC claims manual aligns telehealth and deductible instructions

What changed

The September 29 transmittal is effective October 1 and implemented October 5, and expressly says it makes no policy changes. From October 1, non-behavioral distant-site telehealth uses individual CPT or HCPCS codes describing the service rather than G2025, with the appropriate revenue code and audio-only modifier 93 or audio/video modifier 95. FQHCs do not add an FQHC PPS payment code for these services. Preventive-service deductible and coinsurance waivers remain, without the former need to identify them through the CS modifier.

Mental-health visits through telecommunications retain their separate billing approach equivalent to in-person visits, also distinguishing audio/video from audio-only modifiers. An originating-site facility fee is a different claim component, using Q3014 and revenue code 0780. The manual preserves Part B deductible treatment for that telehealth facility-fee context while generally excluding FQHC services from the deductible and retaining RHC preventive-service exceptions. Those distinctions make one generic telehealth charge or deductible edit inadequate across all three pathways; the manual alignment does not create a new unrestricted telehealth entitlement.

Why it matters
Clinics should reconcile current billing instructions without treating the manual update as a new telehealth entitlement.
Response type
Validate
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Compare clinic billing templates with the updated manual and the previously issued distant-site telehealth instruction.

What to do nextClinic billing owners should validate individual distant-site CPT/HCPCS codes and modifiers for October services, separate mental-health visit and Q3014 rules, test deductible and preventive-service edits, and correct affected claims through the applicable process.

  1. Compare clinic billing templates with the updated manual and the previously issued distant-site telehealth instruction. Revenue Cycle · due Oct 5, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Operationally relevant Proposed comment Nov 14, 2026

Noridian opens five proposed LCDs for comments through November 14

What changed

The October 1 notice identifies automated brain-MRI detection and quantification, DL40454; surgical treatment of nails, DL40462; knee-osteoarthritis hyaluronic-acid injections, DL40456; bacterial-presence fluorescence wound imaging, DL40441; and near-infrared spectroscopy for wound and flap management, DL40458. The comment period runs October 1 through November 14. Each policy has a separate MCD identifier, so the announcement should not be treated as one combined proposed clinical standard.

The listed contracts include California JE coverage along with Nevada and specified Pacific jurisdictions. Noridian directs readers to the CMS Coverage Database for the proposed documents and asks that comments identify the specific policy, using the proposed-LCD submission guidance for email or mail details. Specialty review should therefore begin with the relevant draft itself and its evidence. This announcement does not reproduce all proposed indications or exclusions, adopt them as final, or establish that current claims must immediately follow the proposed restrictions.

Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Response type
Comment
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextRoute the five policy proposals to the affected clinical and billing owners and decide whether to submit evidence before November 14.

  1. Route the five policy proposals to the affected clinical and billing owners and decide whether to submit evidence before November 14. Revenue Cycle · due Nov 14, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Operationally relevant Final

Noridian introduces secure audit file exchange through GoAnywhere

What changed

The September 30 notice describes a secure upload, download, and sharing platform for Audit and Reimbursement work. Providers and approved external partners, including some consultants, preparers, and vendors, may be eligible. The first step is to contact the assigned auditor, who checks the organization's approved email domain and supplies onboarding instructions. After approval, the auditor shares a file or folder so the user can activate an account. Eligibility to exchange audit material is therefore not the same as automatic access for every claims user.

Certain non-provider representatives must give the assigned auditor a completed Medicare Cost Report Third-Party Authorization form before access is approved. The notice links registration guidance, training, and frequently asked questions, and expressly preserves MCReF and the Noridian Medicare Portal as separate applications requiring separate access. GoAnywhere therefore supplies a controlled audit-document channel, rather than a substitute destination for every cost report or claim. An organization should confirm the auditor's requested exchange and representative authority before changing its established filing workflow.

Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.

What to do nextAsk the assigned auditor about eligibility, authorize representatives and configure separate access before using the new exchange workflow.

  1. Ask the assigned auditor about eligibility, authorize representatives and configure separate access before using the new exchange workflow. Revenue Cycle · due Oct 9, 2026
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · due Oct 12, 2026
P3 CARRYOVER Potentially applicable Final implementation Jul 1, 2027

AB 2160 directs updated Medi-Cal lactation guidance

What changed

DHCS must clarify the continuum from lactation education and basic support to clinical consultation, specify appropriate billing and reimbursement procedures, and clarify managed-care plans' coverage and payment responsibilities. The guidance must state that lactation services require no prior authorization, prescription, or referral. It must also require plans to report the number of accessible International Board Certified Lactation Consultants for members needing clinical consultation. These related items address both service access and the operational route for reimbursing the covered work.

The department must seek stakeholder input before issuing the updated guidance, and implementation depends on federal participation and necessary approvals. The act permits letters, bulletins, and similar instructions pending regulations. July 1 is the department's guidance deadline; it is not evidence that particular new codes, rates, or reporting templates already exist as of October 11. Providers and plans therefore need the actual instructions for implementation while preserving current coverage and clinical scope requirements.

Why it matters
Providers need the actual benefit and billing instructions rather than an assumed immediate payment change.
Response type
Monitor
Confidence
High. Current chaptered claim-specific operative clauses read in Chrome. Federal approvals, issued guidance and carrier implementation are not inferred.
Who this affects
Health systems, Provider networks, Health-tech
Jurisdiction
California
Primary owner
Clinical Operations
Affected functions
Clinical Operations, Managed Care, Revenue Cycle
First seen
Oct 4, 2026
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Review current lactation services and monitor the guidance; coordinate plan and provider implementation when the approved instructions are issued. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
Long lead justification
The July 1, 2027 guidance milestone exceeds 180 days, but stakeholder input, lactation-service inventories and billing/network readiness need advance coordination. Track agency and federal-approval dependencies without treating the guidance as already issued. (approved by Brandon Goulter, direct owner instruction executed by Codex, Oct 16, 2026)

What to do nextReview current lactation services and monitor the guidance; coordinate plan and provider implementation when the approved instructions are issued.

P3 NEW Directly applicable Final

Medi-Cal adds code 90616 influenza vaccine benefit

What changed

The October 9 announcement identifies 90616 for the specified intramuscular trivalent mRNA influenza vaccine as a benefit for services on or after August 6, 2026. It lists SA, SB, UD, U7, and 99 as allowable modifiers. The retroactive benefit date therefore differs from publication, and the named code and modifiers need to match the actual billed service rather than being applied to any influenza product.

DHCS says an EPC will reprocess appropriately submitted claims denied because system changes were not yet in place. Providers may also elect corrected resubmission under the manual's claim-inquiry and timeliness instructions. Updated manual sections will be issued later. This describes a route for qualifying system-related denials, not proof of completed payment or a waiver of every billing defect; reconciling denials against any resubmission helps avoid duplicate handling.

Why it matters
DHCS announces EPC reprocessing for appropriate claims denied before system changes and permits corrected resubmission under existing instructions.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations

What to do nextUpdate the charge master and modifier rules; reconcile eligible denials with EPC and corrected submissions. Playbook dates are recommended internal targets, except any explicitly identified agency date.

P3 NEW Directly applicable Final

Medi-Cal updates contracted incontinence products for fee-for-service

What changed

The notice applies from January 1, 2026 service dates to selected Secure Personal Care products on the contracted incontinence creams and washes list. It expressly limits this update to fee-for-service Medi-Cal and directs managed-care members to their own plan's formulary. The announcement does not reproduce individual product numbers or quantities, so it does not independently establish that any particular item dispensed is newly covered or that every manufacturer's products changed.

For appropriately submitted claims denied because the system had not implemented the policy, DHCS plans EPC reprocessing from the effective date. Providers may also use existing corrected-claim and timeliness procedures. The revised contracted list will appear in a future Medi-Cal Update. A claim review therefore needs the applicable product list and delivery system as well as the denial reason; the publication does not show that the list update, system correction, or an individual payment is complete.

Why it matters
The notice is specific to fee-for-service. Managed-care members must consult their plan formulary. EPC and existing corrected-claim instructions address qualifying system-related denials.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Managed Care

What to do nextCompare dispensing and denied claims with the current contracted list; keep managed-care formulary reviews separate. Playbook dates are recommended internal targets, except any explicitly identified agency date.

P3 NEW Directly applicable Withdrawn

Noridian retires draft DCIS biomarker LCD and cancels October 13 meeting

What changed

Noridian retired the proposed MolDX Biomarker Testing for Risk Stratification in DCIS local coverage determination, DL40144, effective October 8, 2026. Its notice identifies the affected JE Part B contracts covering Northern and Southern California, Nevada, Hawaii and listed Pacific territories. It also cancels the Contractor Advisory Committee meeting scheduled for October 13. The date describes retirement of the proposal, not implementation of a new final coverage requirement.

The stated reason is the volume of comments concerning current and impending clinical evidence that the contractor needs to consider. Noridian says further updates will appear on its website and directs readers seeking the retired proposal to the Medicare Coverage Database archive. Providers should distinguish a withdrawn draft from rules actually in force. The notice does not itself establish a new covered indication, universal noncoverage or a replacement proposal’s timing.

Why it matters
The retirement responds to comments about current and emerging evidence. Retiring a proposed LCD does not establish that an existing covered benefit was withdrawn.
Response type
Monitor
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Coding
Affected functions
Coding, Clinical Operations, Revenue Cycle

What to do nextRemove the canceled meeting from monitoring plans and continue using actual operative coverage rules while watching any replacement proposal. Playbook dates are recommended internal targets, except any explicitly identified agency date.

P3 NEW Operationally relevant Final effective Jan 1, 2027

January Medicare common-edit update refreshes external code sets

What changed

CMS’s October 8 transmittal 13984, CR 14640, directs Medicare shared-system maintainers to update Combined Common Edits/Enhancements Modules tables. The change is effective January 1, 2027, with January 4 implementation. It supports version 5010 transactions including 837 institutional claims, 837 professional claims and 276 claim-status inquiries. The recurring update concerns the external code sets those systems use to validate transactions, rather than a new payment policy for a particular clinical service.

The specified tables include ISO country and subdivision codes, state codes for the United States, Canada and Mexico, CMS not-otherwise-classified procedure codes and the listed condition codes permitted on professional transactions. The contractor must maintain the tables, continue checking for updates through the stated release lead time and deliver the NOC code set to CMS thirty days before quarterly releases. Those are contractor duties. A provider’s practical preparation is to confirm its clearinghouse and billing-system code compatibility and examine rejected transactions after the update, without assuming every code-table change affects every claim.

Why it matters
The changes support 837 institutional/professional claims and 276 status inquiries, including country, subdivision, state, NOC procedure and specified condition codes. Contractor delivery requirements are not new provider filing deadlines.
Response type
Implement
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
IT
Affected functions
IT, Revenue Cycle, Coding

What to do nextConfirm January code-table compatibility with the clearinghouse and test affected transactions using valid codes.

P3 NEW Operationally relevant Announced compliance Dec 31, 2026

Optional 2027 MIPS virtual-group election closes December 31

What changed

CMS’s October 8 newsletter announces that the optional 2027 MIPS virtual-group election period opened October 1, 2026. The 2027 participation page sets the closing time at 11:59 p.m. Eastern on December 31. Interested clinicians submit a formal election to [email protected] for CMS approval. This is an election deadline for that reporting option, not automatic enrollment or a requirement that every clinician form a virtual group.

A virtual group combines at least two taxpayer identification numbers, each with ten or fewer clinicians, and must meet CMS’s composition requirements. For 2027, it reports through traditional MIPS; the APP and MVP pathways are unavailable to virtual groups. CMS assesses performance at the virtual-group level, and each MIPS-eligible clinician’s payment adjustment follows that group score even when another participation route produces a higher score under the same TIN/NPI combination. Practices should therefore evaluate their combined reporting and scoring consequences before electing, rather than treating the choice as an administrative filing alone.

Why it matters
Eligible practices choosing virtual-group participation must elect by December 31. The option does not impose a new election duty on every clinician.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Quality
Affected functions
Quality, Clinical Operations, Compliance

What to do nextEvaluate eligibility and coordination needs before deciding whether to elect; follow the CMS toolkit if choosing this option.

P3 NEW Directly applicable Announced

Medi-Cal navigator funding applications are due October 30

What changed

Applications released October 1 support two programs. The H.R. 1 Navigators for Clinics program has $5.5 million to help ACA adult-expansion members maintain coverage and understand changing eligibility procedures. Separately, the UIS Transition Navigators program has $8 million in General Funds to help members preserve access while moving from managed care to fee-for-service. The announcement describes navigation support around forthcoming changes; it does not independently establish that every underlying federal eligibility provision starts January 1.

Eligible applicants are community health centers and community organizations that previously delivered navigation through DHCS/CPCA initiatives. Applications are due October 30. CPCA anticipates approximately 8–15 clinic-program grantees and 28–45 UIS-program grantees, with awards of $150,000–$500,000 per direct service entry. These are announced ranges and expectations, rather than awarded grants or guaranteed funding for every applicant. Organizations should confirm eligibility and application details with the program administrator, then match staffing and member outreach to the relevant population; UIS delivery-system assistance and adult-expansion eligibility counseling serve different needs.

Why it matters
Eligibility is limited to community health centers and community organizations that previously provided navigation through DHCS/CPCA initiatives. Announcement of navigator funding does not itself establish every federal eligibility change on January 1.
Response type
Assess
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
California
Primary owner
Patient Access
Affected functions
Patient Access, Population Health, Finance, Managed Care

What to do nextEligible organizations should confirm program eligibility, staffing and application requirements with the administering program before committing resources. Keep UIS delivery-system assistance separate from ACA adult-expansion eligibility counseling.

  1. Confirm prior-program eligibility and applicable navigator opportunity. Internal target. Patient Access · due Oct 18, 2026
  2. Submit an application only if the organization elects to pursue the funding opportunity. Finance · due Oct 30, 2026
P3 NEW Potentially applicable Announced

CMS publishes California rural-health obligated-funds snapshot

What changed

CMS’s RHTP Obligated Funds Report records California’s first-budget-period award of $233,639,308.47 and $219,133,495 in funds put to work as of July 31, 2026. Its California page includes hospital transformation payments, hub-and-spoke partnerships, rural workforce capacity and retention, and technology infrastructure. The reporting period began December 29, 2025. These figures describe historical state-submitted obligations, rather than a new award announced for providers during the October publication week.

The report covers obligations to agencies, contractors, vendors, community partners and facilities and expressly says it is not a full account of state progress. CMS plans a refresh after the November 30 quarterly report, then quarterly updates. Rural organizations can use the initiative descriptions to identify relevant state programs, but should verify eligibility, application windows and actual disbursements separately. Neither an obligation total nor a named initiative establishes that a particular provider has been paid or can apply immediately.

Why it matters
These are historical obligations, not proof of disbursement, a complete progress assessment or a new October funding award. Rural providers can use the snapshot to identify relevant state initiatives.
Response type
Monitor
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal, California
Primary owner
Finance
Affected functions
Finance, Clinical Operations

What to do nextFinance and rural program leadership should compare existing participation with state initiative notices and separately verify any current eligibility or application window. CMS plans an update after the November 30 state quarterly report; this report creates no new provider application deadline.

Watch NEW Potentially applicable Announced

CMS explains the optional CCBHC state plan benefit

What changed

The October 6 letter implements authority enacted in 2024. Participating states certify clinics against current CCBHC criteria, with nine statutory service categories, additional required services, and ongoing encounter/outcome reporting. A community needs assessment informs staffing. Formal collaborating-provider arrangements may deliver services under the clinic umbrella, while access obligations include crisis availability and acceptance regardless of ability to pay or residence.

The state-plan option is distinct from the existing demonstration. A transitioning demonstration state may retain its payment methodology but must submit a state-plan amendment for CMS approval before implementation. The demonstration's enhanced matching rate does not automatically carry over to state-plan expenditures. The letter establishes a federal option and implementation conditions; it does not itself demonstrate California adoption, certify a particular clinic, or establish a provider-specific payment.

Why it matters
State certification uses current criteria, nine required services and ongoing reporting. CCBHCs serve people regardless of ability to pay or residence. The federal option is not evidence that California has adopted it.
Response type
Monitor
Confidence
High
Who this affects
Health systems, Provider networks
Jurisdiction
Federal
Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Finance

What to do nextTrack California adoption and certification decisions; compare staffing, access and collaborating-provider agreements before making reimbursement assumptions. Playbook dates are recommended internal targets, except any explicitly identified agency date.

Active implementation tracker

Every P1 and P2 development stays here until it closes, including items whose narrative is suppressed this week.

P2CARRYOVER

CMS reports $1.6 billion in Medicare laboratory program integrity actions across revocations, suspensions, recoupments and referrals

Primary owner
Revenue Cycle
Affected functions
Compliance, Revenue Cycle, Coding, Clinical Operations, Provider Enrollment, Finance, Legal
Last materially changed
Oct 4, 2026
Why it is still here
The current full release and October 1 duplicate-testing guidance were reread. Risk monitoring remains material; no new general duty was identified in these sources.
P2CARRYOVEROct 12, 2026

Noridian finalizes two MolDX coverage policies for California effective October 12 and retires the thrombophilia policy October 11

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations, Compliance, Utilization Management, HIM/CDI
Last materially changed
Aug 30, 2026
Why it is still here
Current Noridian notices and CMS effective-date/coverage sections were rechecked. The immediate retirement and next-day implementation remain material; organization-specific completion is not known.
P2CARRYOVEROct 26, 2026

CMS proposes a new annual Acute Hospital Care at Home reporting requirement, comments close October 26

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Quality, HIM/CDI, Finance, Case Management
Last materially changed
Aug 30, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Confirm whether the organization participates in the Acute Hospital Care at Home initiative. If it does, ask the program owner whether clinician visit, food service, and pharmacy service counts can be produced from current documentation, name a data owner for each of the three counts, and decide by October 26, 2026 whether to comment on the burden estimate.
P2CHANGEDOct 1, 2026

Medi-Cal directory administrators must confirm successful submissions

Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Revenue Cycle, Compliance, IT, Patient Access
Last materially changed
Oct 11, 2026
Why it is still here
The consequence is disproportionate to the task and lands on the wrong people. One administrator failing to answer a survey removes Provider Portal Transaction Center access for every user in the organization, which is an eligibility, claims and transaction outage rather than a directory problem. The obligation recurs every quarter, so it needs a calendared owner and a named backup rather than a one time assignment, and organizations with many service locations have to answer the accepting new patients question accurately for each one, which is a data question the enrollment team may not own today.
P2CARRYOVEROct 13, 2026

California challenges Medicaid and CHIP funding restrictions scheduled for October 13

Primary owner
Legal
Affected functions
Legal, Managed Care, Revenue Cycle, Clinical Operations
Last materially changed
Sep 6, 2026
Why it is still here
Funding and continuity preparations remain material two days before the stated federal date. The announcement and current DHCS funding summary were read, but later docket status remains unresolved.
P2CARRYOVER

OIG identifies $587.7 million in Part D payments involving obsolete prescription labeling

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Revenue Cycle
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Pharmacy and Managed Care owners should assess Rx-to-OTC monitoring, reference-file updates and claims review with counsel, and monitor implementing CMS guidance.
P2CARRYOVER

OIG flags organ acquisition reimbursement and documentation risks

Primary owner
Finance
Affected functions
Finance, Clinical Operations, Compliance, Legal
Last materially changed
Sep 6, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Finance and transplant operations should trace organ counts to disposition and supporting records, consult counsel on the guidance conflict, and monitor MAC instructions before treating the estimate as an organization-specific liability.
P2CHANGEDSep 1, 2026

Medi-Cal hospice attestation reminder emphasizes correct NPI selection

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Revenue Cycle, Provider Enrollment, IT, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
Late submission can cause claim denial. The FAQ limits this portal to fee-for-service providers; managed care providers follow their plan procedures. The signed DHCS 8052 informed-consent form remains in the medical record and is not submitted through the portal.
P2CARRYOVERJul 1, 2027

AB 280 establishes provider directory reliance protections

Primary owner
Managed Care
Affected functions
Managed Care, Patient Access, Compliance, IT
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Directory and contracting teams should map the central utility, notice, reliance and reinstatement requirements to affected products and validate member workflows before the operative date. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 350 expands fluoride treatment coverage and guidance

Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, IT, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Separate commercial benefit configuration from Medi-Cal implementation; confirm approved scope, provider eligibility and DHCS billing guidance before changing claims rules. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1682 adds qualifying scalp cooling coverage

Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, IT, Clinical Operations, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1876 strengthens health plan nondiscrimination protections

Primary owner
Compliance
Affected functions
Compliance, Legal, Managed Care, IT, Patient Access
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Test enrollment, benefit, claim and member service workflows against the protected bases; revise escalation and denial review controls. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERMay 26, 2028

AB 2499 sets a future electronic exchange standard for claim support

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Managed Care, Compliance, Finance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map current claim attachment workflows and vendor dependencies to the final exchange requirements; verify implementation milestones as standards and guidance develop. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERSep 30, 2026

CMS announces broad state participation in the GENEROUS Medicaid drug payment model and a September 30 signing date

Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Finance, Compliance, IT
Last materially changed
Sep 20, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Confirm California participation status and assigned state owner, inventory supplemental-rebate and federal-share workflows, and identify any data, invoice, formulary, or manufacturer-contract changes needed before operational instructions issue.
P2CARRYOVER

CMS expands ACCESS to heart failure, COPD, substance use disorder, nicotine dependence, and extended musculoskeletal care in spring 2027

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Managed Care, IT, Compliance, Finance
Last materially changed
Sep 20, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Identify eligible service lines and referral owners, assess data and device integration, and compare current chronic-care contracts with ACCESS outcome measures before deciding whether to participate or refer.
P2CARRYOVEROct 5, 2026

CMS replaces the October Medicare EDI front-end update to correct two edit-spreadsheet errors

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Compliance, Finance
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Replace the August spreadsheet with the corrected September version, regression-test affected 276/277 and claim-front-end scenarios, and confirm vendor deployment before October 1.
P2CARRYOVER

California limits added billing barriers for Medi-Cal providers after other coverage pays

Primary owner
Managed Care
Affected functions
Managed Care, Revenue Cycle, Compliance, IT
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; ongoing implementation or monitoring remains: Compare coordination-of-benefits edits, noncontracted-provider billing rules, and letter-of-agreement practices with the enacted limits, then prepare changes that activate after required federal approval and funding.
P2CARRYOVERJan 1, 2027

CMS finalizes 2027 Ambulatory Specialty Model participation and reporting steps

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Quality, Finance, IT, Compliance
Last materially changed
Sep 20, 2026
Why it is still here
Current claim reviewed; remaining operational task: Confirm selection status, assign an executive owner, calendar each CMS reporting and attestation step, and test source data before the 2027 model year.
P2CHANGEDNov 1, 2026

Noridian coverage updates include November tendon-injection conformity revisions

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Utilization Management, Clinical Operations, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
Current November implementation work, with two newly announced conformity revisions; prior source verification is retained without advancement.
P2CARRYOVERJan 1, 2027

DHCS prepares a January 1 transition to fee-for-service for specified immigration-status coverage

Primary owner
Managed Care
Affected functions
Managed Care, Patient Access, Revenue Cycle, Case Management, Compliance, IT
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CARRYOVEROct 5, 2026

CMS issues FY 2027 IPPS and LTCH implementation instructions

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Finance, Coding, IT, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Retained for date-specific implementation and applicable claim testing after claim-specific current official instruction review.
P2CARRYOVERJan 1, 2027

ACWDL 26-16: Pickle, DAC and DW asset-limit reinstatement

Primary owner
Patient Access
Affected functions
Patient Access, Compliance, IT, Case Management
Last materially changed
Sep 20, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CARRYOVEROct 21, 2026

CMS releases preliminary 2027 Clinical Laboratory Fee Schedule rates

Primary owner
Revenue Cycle
Affected functions
Clinical Operations, Revenue Cycle, Finance, Compliance
Last materially changed
Sep 27, 2026
Why it is still here
Current claim reviewed; remaining operational task: Model the preliminary rates against current volume, identify material changes, and submit supported comments or reconsideration requests by October 21.
P1CARRYOVEROct 5, 2026

CMS revises the October NCD coding update and moves stem-cell changes to April 2027

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, IT, Compliance
Last materially changed
Sep 27, 2026
Why it is still here
Current transmittal scope and business requirements read October 11; retained for post-implementation reconciliation. The linked ZIP spreadsheets and actual contractor implementation were not inspected.
P1CARRYOVEROct 1, 2026

Noridian posts MolDX billing-article revisions for October 1

Primary owner
Revenue Cycle
Affected functions
Clinical Operations, Revenue Cycle, Coding, Compliance
Last materially changed
Sep 27, 2026
Why it is still here
Retained to validate applicable October coding and test-specific billing controls after current operative article review; the prior September revisions remain historical.
P2CARRYOVEROct 12, 2026

DHCS seeks comment on payment responsibility for psychiatric emergency services

Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Revenue Cycle, Compliance
Last materially changed
Sep 27, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P1CARRYOVEROct 1, 2026

Hospice election addendum is mandatory for every new election starting October 1

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Revenue Cycle
Last materially changed
Oct 4, 2026
Why it is still here
The operative newsletter section was reread. Ongoing election workflows remain material after implementation; October through December enforcement discretion does not make the addendum optional.
P1CARRYOVEROct 13, 2026

Medi-Cal youth gender-affirming services: October 13 reimbursement and continuity requirements

Primary owner
Managed Care
Affected functions
Managed Care, Clinical Operations, Case Management, Revenue Cycle, Legal
Last materially changed
Oct 4, 2026
Why it is still here
The complete current six-page letter was visually read by the machine. The imminent service-date transition remains material; later court status and Attachment A were not independently verified.
P2CARRYOVER

OIG finds $72 million in MA and Part D payments tied to excluded or felony-convicted providers

Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Managed Care, Compliance, Revenue Cycle
Last materially changed
Oct 4, 2026
Why it is still here
The current primary findings were read. The historical audit remains useful for delegated payment controls; no new mandate or current-week recovery was inferred.
P2CARRYOVERApr 1, 2027

GLOBE final model: manufacturer rebates and selected Part B drug coinsurance preparation

Primary owner
Finance
Affected functions
Finance, Revenue Cycle, Clinical Operations, Managed Care
Last materially changed
Oct 4, 2026
Why it is still here
Retained for date-specific implementation and applicable claim testing after claim-specific current official instruction review.
P2CHANGEDOct 1, 2026

FY 2027 IPF payment correction changes per diem and ECT amounts

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
Small rate differences propagate across claims, budget models and vendor configuration. Using the uncorrected final-rule table can produce systematic discrepancies. The cap may increase for awarded resident slots from July 1, 2026, including qualifying IPPS-hospital slots allocated to an IPF subunit. Do not double-count resident time under IPPS IME or aggregate IPF caps through affiliation agreements.
P2CHANGEDOct 1, 2026

IRF October reminder separates clinical timing rules, corrected rates and later QRP deadlines

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Quality, Revenue Cycle, IT
Last materially changed
Oct 11, 2026
Why it is still here
Current clinical and payment implementation, with a newly published MAC reminder and a more complete review of operative phased duties.
P2CARRYOVEROct 5, 2026

Hospice FY 2027 payments and corrected aggregate impact estimate

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Use the applicable wage-adjusted rate and quality-reporting adjustment; reconcile the replacement instructions and distinguish the aggregate impact estimate from the payment update.
P2CARRYOVERNov 2, 2026

CMS clarifies Medicare priority relative to FEHBP for federal annuitants receiving OWCP benefits

Primary owner
Patient Access
Affected functions
Patient Access, Revenue Cycle, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Review federal-annuitant payer-order scripts and refer unusual workers compensation claims for separate MSP analysis.
P2CARRYOVERNov 2, 2026

Home health certification manual incorporates allowed practitioners

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Compliance, Provider Enrollment
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Validate certification templates, practitioner credentials and supporting medical records against the revised manual while preserving all other eligibility requirements.
P2CARRYOVEROct 30, 2026

Medicare EDI manual supports the TCEDI gateway

Primary owner
IT
Affected functions
IT, Revenue Cycle, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Review the revised EDI manual with the clearinghouse and MAC. Test applicable acknowledgements and escalation contacts; do not infer an unsupported provider migration deadline from the manual revision.
P2CARRYOVERJan 1, 2027

January 2027 home health grouper uses version 08.0.27

Primary owner
IT
Affected functions
IT, Coding, Revenue Cycle, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Current cited claim reviewed; remaining preparation or control action: Schedule vendor installation and regression checks for claim From dates straddling January 1, and reconcile grouping to CMS documentation.
P2CARRYOVERJan 1, 2027

CMS issues January ASP, MPFS and ZIP-code system update instructions

Primary owner
IT
Affected functions
IT, Revenue Cycle, Coding, Finance
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Inventory the three releases and test the first January implementation. Monitor subsequent corrections and the applicable final payment policies separately.
P2CARRYOVER

Acute Hospital Care at Home telehealth billing uses hospital POS 21

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Validate AHCAH charge mapping, professional billing interfaces and payer-specific claim edits with the hospital billing team.
P2CARRYOVER

Short-term acute care PEPPER report is available through CMS identity controls

Primary owner
Compliance
Affected functions
Compliance, HIM/CDI, Revenue Cycle
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Confirm authorized report access, review hospital-specific outlier areas and choose documentation samples with Compliance.
P2CARRYOVEROct 31, 2026

Refugee medical assistance period corrected to twelve months

Primary owner
Patient Access
Affected functions
Patient Access, Case Management, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Review applicable refugee medical assistance cases and reconcile state implementation and outreach instructions before changing eligibility workflows.
P2CARRYOVEROct 1, 2026

SNF FY 2027 correction revises wage-index calculations and burden estimates

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Current claim reviewed; remaining operational task: Reconcile the affected FY 2027 SNF rate tables and wage-index calculations against the corrected publication.
P2CARRYOVER

California IRF ownership changes require correct RCD selections and new identifiers

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CARRYOVEROct 1, 2026

Noridian October coding updates change FFR, infusion-pump and SAD billing

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CARRYOVER

Medi-Cal updates maintenance dialysis billing for restricted-scope members

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Patient Access, Clinical Operations, Managed Care
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CARRYOVERNov 29, 2026

RHC and FQHC timeliness waiver opens for eligible LMFT and psychological associate claims

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Retained for applicable implementation or monitoring after claim-specific official source review; this is not a new issuance in the closed October 4–10 window.
P2CHANGED

DOJ corporate fraud directive expands healthcare program-integrity targeting signals

Primary owner
Compliance
Affected functions
Compliance, Legal, Executive Leadership, Revenue Cycle
Last materially changed
Oct 11, 2026
Why it is still here
The directive expressly includes healthcare fraud and instructs prosecutors on tax, securities and consumer charges. It governs prosecutor methods; it establishes no new provider implementation deadline.
P2CARRYOVERJan 1, 2027

SB 1049 gives qualifying claim corrections a minimum filing period

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Managed Care, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map covered corrections, trigger dates and submission evidence; update work queues and payer communications. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1629 changes noncontracted dental assignment of benefits

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Patient Access, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Review assignment documents, estimate disclosures and payment handling before applying the new pathway. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

SB 950 adds qualifying dementia treatment coverage protections

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm covered contracts, FDA criteria and antiamyloid access; retain lawful review and member-specific medical necessity. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1843 limits prior authorization for covered hepatitis C antivirals

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Identify affected products and statutory scope, revise qualifying prior authorization edits and validate dispensing and claims workflows. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1887 sets rare disease drug authorization timing

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm covered drugs, prescriber expertise and required request content; monitor response timing and escalate delays. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

SB 964 creates a qualifying drug dose adjustment request pathway

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Create a qualifying request template, document each condition and track written responses for covered commercial products. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 15, 2027

SB 1094 changes biosimilar substitution and formulary requirements

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Reconcile dispensing authority, prescriber instructions, formulary selection and member continuity exceptions. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 1906 adds qualifying cervical screening home test coverage

Primary owner
Managed Care
Affected functions
Managed Care, Compliance, Clinical Operations
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Confirm order, network and kit requirements and benefit edits; track separate Medi-Cal implementation guidance. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJan 1, 2027

AB 2348 revises Medi-Cal enhanced care management implementation

Primary owner
Case Management
Affected functions
Case Management, Managed Care, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Map existing ECM and community support workflows to the final provisions and subsequent DHCS instructions; validate training and plan reporting responsibilities. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2CARRYOVERJul 1, 2027

SB 874 requires BHT employee background checks and stakeholder-informed policy

Primary owner
Clinical Operations
Affected functions
Clinical Operations, Managed Care, Revenue Cycle, Compliance
Last materially changed
Oct 4, 2026
Why it is still here
Implementation remains open: Track DHCS forums and billing guidance and compare resulting changes with current provider controls. The official all-measures history search returned no October 4–10 actions; this is carryover implementation, not a new weekly enactment.
P2NEW

2027 Star Ratings link enrollment planning to 2028 bonus payments

Primary owner
Quality
Affected functions
Quality, Managed Care, Finance, Population Health
Last materially changed
Oct 11, 2026
Why it is still here
Improving physical and mental health measure weights rise from one to three; new measures and retired measures change comparisons. Do not confuse the rating year, underlying performance period and bonus year.
P2NEWJan 1, 2027

DHCS specifies BHSA service claiming codes for January 2027

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations, IT, Managed Care
Last materially changed
Oct 11, 2026
Why it is still here
Tracking modifiers support performance measurement and do not affect adjudication. HFW requires monthly bundled claiming; forthcoming HFW guidance remains a dependency. Housing interventions are not claimed as SMHS, DMC or DMC-ODS through Short Doyle.
P2NEWJul 9, 2027

HCBS compensation reporting guidance separates 2027 readiness from 2028 reports

Primary owner
Finance
Affected functions
Finance, Managed Care, Clinical Operations, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
The guidance reaches specified 1915 and 1115 HCBS authorities in fee-for-service and managed care. It excludes the section 1905(a) personal care, home health and case management benefits. It does not make the separate 80 percent compensation rule immediately operative.
P2NEWApr 5, 2027

Medicare SNF place of service utility will reprocess overlapping claims

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Finance, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
POS 31 reflects Part A covered SNF stays, while POS 32 reflects nursing facilities or noncovered SNF stays. Reprocessing can create recoupments. The actual PDF identifies CR 14582, while its landing-page reference differs.
P2NEWFeb 1, 2027

DMEPOS Round 2028 registration and bid dates are announced

Primary owner
Provider Enrollment
Affected functions
Provider Enrollment, Finance, Managed Care, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
The covered-document review date is February 8, 2027; contracts begin January 1, 2028. The published timeline labels dates as targets. Supplier networks should avoid assuming an opening later in 2026.
P1NEW

DHCS warns assisted living waiver facilities of denials and reprocessing

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Case Management, Compliance, Finance
Last materially changed
Oct 11, 2026
Why it is still here
Facilities and care coordination agencies must verify ALW eligibility, program compliance, correct codes and documentation. The notice announces oversight and facility-specific follow-up, without inventing a universal correction deadline.
P1NEWOct 15, 2026

Medi-Cal clinic institutional claims require diagnosis codes from October 15

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, IT, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
The trigger is claim submission, rather than a new date-of-service limit. DHCS says corresponding provider manual updates will follow.
P2NEW

Medi-Cal RSV vaccine billing expands age eligibility and modifier rules

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, IT
Last materially changed
Oct 11, 2026
Why it is still here
DHCS will implement an erroneous-payment correction for appropriately submitted claims denied because system changes were missing. Providers may also correct and resubmit under existing timeliness instructions.
P2NEW

Every Woman Counts adds retroactive procedure and diagnosis benefits

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
Breast-density diagnoses date to October 1, 2023; pelvic-pain diagnosis changes date to October 1, 2025. The notice's EPC language refers to affected claims up to October 26, 2024; do not expand that wording into a guaranteed correction period.
P2NEWNov 1, 2026

Medi-Cal obstetric E/M transition retains CPSP and doula exceptions

Primary owner
Coding
Affected functions
Coding, Clinical Operations, Revenue Cycle, IT
Last materially changed
Oct 11, 2026
Why it is still here
Select E/M by documented time or complexity. Prenatal and postpartum diagnosis rules apply; CPSP providers and doulas must continue local Z codes until further notice. Encouragement is not a blanket immediate ban on every existing code.
P2NEWApr 1, 2027

Hospice claim edits gain transfer and ownership-change bypasses in April 2027

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Clinical Operations, IT
Last materially changed
Oct 11, 2026
Why it is still here
The edits compare claim admission dates with election-period starts. CMS temporarily disabled them June 18, 2026 pending these bypasses. Reimplementation must preserve the receiving hospice's valid admission date and ownership-notice date; this CR states no new policy.
P2NEWApr 1, 2027

Home health edit repair addresses purged Notices of Admission

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
FISS can purge the corresponding NOA before late claims arrive. The specified repair accepts these claims and passes the admission date to the pricer in the receipt-date field. It states no new policy and does not waive all filing limits or other claim requirements.
P2NEWOct 1, 2026

October ASC update changes codes, skin substitutes and retroactive pricing

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, Clinical Operations, IT
Last materially changed
Oct 11, 2026
Why it is still here
The update replaces C8010 with 1091T; revises skin-substitute add-on descriptors retroactive to April 1; adds codes and retires drug codes September 30. MACs reprocess A9521 from May 14 and J9161 from July 1 through September 30 within 30 days of implementation. Stimuplex joins C9812 effective April 30. A code or rate does not establish coverage.
P2NEWJan 1, 2027

Home health consolidated billing removes two supply codes in January

Primary owner
Coding
Affected functions
Coding, Revenue Cycle, IT
Last materially changed
Oct 11, 2026
Why it is still here
No therapy-code additions are announced. The update changes coding used to enforce existing consolidated billing, rather than redefining the entire covered service set. Removal does not establish automatic payment or coverage.
P2NEWDec 1, 2026

HETS users must correct report-delivery email before December suspension test

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, IT, Provider Enrollment
Last materially changed
Oct 11, 2026
Why it is still here
Failed monthly report delivery on October 1, November 1 and December 1 suspends HETS EDI eligibility requests for all provider NPIs until corrected. Vendors cannot change a provider's enrollment email.
P2NEW

Noridian repairs G0260 imaging-code payment edit retroactively

Primary owner
Revenue Cycle
Affected functions
Revenue Cycle, Coding, Clinical Operations
Last materially changed
Oct 11, 2026
Why it is still here
The remaining 13X bill-type and listed diagnosis conditions continue. This edit repair does not remove all sacroiliac injection coverage or documentation requirements.
P1NEWOct 13, 2026

Unpaid qualifying APM participants face October 13 billing-information cutoff

Primary owner
Finance
Affected functions
Finance, Provider Enrollment, Revenue Cycle, Quality
Last materially changed
Oct 11, 2026
Why it is still here
The advisory concerns 2024 QP performance, a 2025 payment base and the 2026 incentive payment, with forfeiture after October 13. Listed unpaid clinicians and others expecting an unpaid incentive should follow the official instructions. One later paragraph says 2025 incentive; that apparent source inconsistency is not silently treated as a different payment period.
P2NEWDec 1, 2026

Recuperative care changes preserve phased housing sunset and member transitions

Primary owner
Case Management
Affected functions
Case Management, Managed Care, Clinical Operations, Utilization Management, Revenue Cycle, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
MCPs offering STPHH must send standardized member notices by December 1, support transitions, update provider agreements and January materials, and report monthly through December; the last report is due January 10. Reduced requested authorizations can trigger appeal rights. Earlier room-and-board months still count during the rolling-cap runout.
P2NEWOct 16, 2026

Recuperative-care pricing feedback closes October 16

Primary owner
Finance
Affected functions
Finance, Managed Care, Clinical Operations, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
The benchmark excludes room and board and supports negotiations. It is neither a required rate nor a floor or ceiling; acuity, staffing, caseload and geography affect actual costs.
P2NEW

Four county behavioral-health plans remain subject to temporary network withholds

Primary owner
Managed Care
Affected functions
Managed Care, Finance, Quality, Clinical Operations, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
DHCS will not proceed against Fresno, Napa, San Mateo, Tehama, Tulare or Ventura after corrective evidence. The remaining withholds are released upon demonstrated compliance. This is a historical action update, not an October 5 civil settlement or an announced permanent penalty.
P2NEWJan 1, 2027

Behavioral-health data sharing needs separate MCP and county implementation phases

Primary owner
IT
Affected functions
IT, Compliance, Managed Care, Clinical Operations, HIM/CDI
Last materially changed
Oct 11, 2026
Why it is still here
Monthly rosters and bidirectional ADT notifications support coordination, but required reporting exchange need not be real time. Part 2 roster disclosures require valid consent. CalAIM permissions do not override federal privacy restrictions, and revocation protects information not yet disclosed.
P2NEWDec 1, 2026

Qualified non-citizen notices distinguish funding from January care delivery

Primary owner
Patient Access
Affected functions
Patient Access, Managed Care, Case Management, Provider Enrollment, Compliance
Last materially changed
Oct 11, 2026
Why it is still here
Automatic funding transition does not mean the later delivery system is unchanged. The letter asks members with changed or inaccurate immigration information to update county records by December 1 and check whether current providers accept FFS. This population must not be conflated with UIS.

Forward implementation horizon, next 180 days

What is coming, what triggers it, and what to do before it lands.

Corrections to this edition

These corrections revise this dated edition. Its original publication date and permanent link stay the same.

  1. Version 2 · Oct 15, 2026

    Expanded the selected article with source-grounded background and clarified its summary and wording.

  2. Version 3 · Oct 16, 2026

    Expanded October 11 articles with source-grounded background, material details and clearer implications; corrected source-fidelity wording. Original dates and permanent article links are retained.

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies